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Abstract 
 Methods for using GWAS to estimate genetic correlations between pairwise combinations of traits have 
produced “atlases” of genetic architecture. Genetic atlases reveal pervasive pleiotropy, and genome-wide 
significant loci are often shared across a wide variety of social, behavioral, and psychiatric phenotypes. 
We introduce genomic structural equation modeling (Genomic SEM), a multivariate method for 
analyzing the joint genetic architectures of complex traits. Using formal methods for modeling covariance 
structure, Genomic SEM synthesizes genetic correlations and SNP-heritabilities inferred from GWAS 
summary statistics of individual traits from samples with varying and unknown degrees of overlap. 
Genomic SEM can be used to model multivariate genetic associations among phenotypes, identify 
variants with effects on general dimensions of cross-trait liability, boost power for discovery, and 
calculate more predictive polygenic scores. Finally, Genomic SEM can be used to identify loci that cause 
divergence between traits, aiding the search for what uniquely differentiates genetically correlated 
phenotypes. We demonstrate several applications of Genomic SEM, including a joint analysis of GWAS 
summary statistics from five genetically correlated psychiatric traits. We identify 27 independent SNPs 
not previously identified in the contributing univariate GWASs of the five traits. Five of these 27 
independent SNP have been reported in separate, published GWASs of the included traits. Polygenic 
scores derived from Genomic SEM consistently outperform polygenic scores derived from GWASs of the 
individual traits. Genomic SEM is flexible, open ended, and allows for continuous innovations in how 
multivariate genetic architecture is modeled. 
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Genomic Structural Equation Modeling 
 Genome-wide association studies (GWASs) are rapidly identifying loci affecting multiple social, 
behavioral, and psychiatric phenotypes.1,2 Moreover, using cross-trait versions of methods such as 
genomic-relatedness-based restricted maximum-likelihood (GREML)3 and LD-score regression (LDSC)4 
researchers have identified genetic correlations between diverse traits, e.g., age of first birth and risk of 
smoking,5 insomnia and psychiatric traits (e.g., schizophrenia),6 major depressive disorder and number of 
children,7 and educational attainment and cognitive performance.8 In fact, widespread pleiotropy appears 
to be the rule rather than the exception across psychiatric, cognitive, economic, and social indices. 
Although these findings are currently suggestive of constellations of phenotypes affected by shared 
sources of genetic liability, existing methods do not permit the causes of the observed genetic correlations 
to be investigated systematically. Here we introduce Genomic Structural Equation Modeling (Genomic 
SEM), a new method for modeling the multivariate genetic architecture of constellations of traits and 
incorporating genetic covariance structure into multivariate GWAS discovery. Genomic SEM is a flexible 
framework for formally modeling the genetic covariance structure of complex traits using GWAS 
summary statistics from samples of varying and potentially unknown degrees of overlap, in contrast to 
existing methods that model phenotypic covariance structure,9 with very specific applications,10 using raw 
data. Moreover, Genomic SEM allows for the specification and comparison of a range of different 
hypothesized multivariate genetic architectures, which improves upon existing approaches for combining 
information across genetically correlated traits to aid in discovery.11 
One powerful feature of Genomic SEM is the capability to model shared genetic architecture 
across phenotypes with factors that may be treated as broad genetic liabilities, and to compare the fit of 
different factor structures to the empirical data. When an appropriate model has been identified at the 
level of the genome-wide covariance structure, the researcher may incorporate individual SNPs into the 
model in order to identify variants with effects on general dimensions of cross-trait liability, boost power 
for discovery, and calculate more valid and predictive polygenic scores. Genomic SEM can also evaluate 
whether the multivariate genetic architecture implied by a specific model is applicable at the level of 
individual variants using developed estimates of heterogeneity. When certain SNPs only influence a 
subset of genetically correlated traits, a key assumption of other multivariate approaches is violated.11 
SNPs with high heterogeneity estimates can be flagged as likely to confer disproportionate or specific 
liability toward individual traits or disorders, can be removed when constructing polygenic risk scores, or 
studied specifically to understand the nature of heterogeneity. These heterogeneity estimates act as 
safeguards against false inference when considering a locus specific to one trait in its effect on a set of 
correlated traits. 
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We validate key properties of Genomic SEM with a series of simulations and illustrate the 
flexibility and utility of Genomic SEM with several analyses of real data. These include a joint analysis of 
GWAS summary statistics from five genetically correlated psychiatric case-control traits: schizophrenia, 
bipolar disorder, major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and anxiety. 
We model genetic covariances among the traits using a general factor of psychopathology (p), for which 
we identify 27 independent SNPs not previously identified in the univariate GWASs, 5 of which can be 
validated based on separate GWASs. Polygenic scores derived using this p-factor consistently outperform 
polygenic scores derived from GWASs of the individual traits in out-of-sample prediction of psychiatric 
symptoms. Other demonstrations include a multivariate GWAS of neuroticism items, an exploratory 
factor analysis of anthropometric traits, and a simultaneous analysis of the unique genetic associations 
between schizophrenia, bipolar disorder, and educational attainment. 
 
Results 
Genomic SEM is a Two-Stage Structural Equation Modeling approach.12-14 In Stage 1, the 
empirical genetic covariance matrix and its associated sampling covariance matrix are estimated. The 
diagonal elements of the sampling covariance matrix are squared standard errors (SEs). The off-diagonal 
elements index the extent to which sampling errors of the estimates are associated, as may be the case 
when there is sample overlap across GWAS. In principle, these matrices may be obtained using a variety 
of methods for estimating SNP heritability, their genetic covariance, and their SEs. Here we use a novel 
version of LDSC that accounts for potentially unknown degrees of sample overlap by populating the off- 
diagonal elements of the sampling covariance matrix. The same strengths, as well as assumptions and 
limitations, that are known to apply to LDSC15,16 apply to its extension used here and to Genomic SEM. 
In Stage 2, a SEM is estimated by minimizing the discrepancy between the model-implied genetic 
covariance matrix and the empirical covariance matrix obtained in the previous stage. We highlight 
results from weighted least squares (WLS) estimation that weights the discrepancy function using the 
inverse of the diagonal elements of the sampling covariance matrix, and produces model SEs using the 
full sampling covariance matrix. In the Online Supplement, we report results from an alternative normal 
theory maximum likelihood (ML) estimation method. We evaluate fit with the standardized root mean 
square residual (SRMR), model 2, Akaike Information Criteria (AIC), and Comparative Fit Index (CFI; 
Online Method).13,17 
Genomic SEM can be employed as a tool for multivariate GWAS based on univariate summary 
statistics. First, the genetic covariance matrix and its associated sampling covariance matrix are expanded 
to include SNP effects. A Genomic SEM is then specified in which SNP effects occur at the level of a 
latent genetic factor defined by several phenotypes, at the level of the genetic component of each of 
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several (potentially genetically correlated) phenotypes, or some combination of the two. The Genomic 
SEM is then run once per SNP (or each set of SNPs, should the user incorporate multiple SNPs into a 
model) to obtain its effects within the multivariate system. 
We provide an index that quantifies the extent to which an observed vector—consisting of 
univariate regression effects of a given SNP on each of the phenotypes—can be explained by a common 
pathway model that assumes that the effects on the phenotypes are entirely mediated by the common 
genetic factor(s). In other words, the index enables the identification of loci that do and do not operate on 
the individual phenotypes exclusively by way of their associations with the common factor(s). Because of 
its intuitive and mathematical similarity to the meta-analytic Q-statistic used in standard meta-analyses to 
index heterogeneity of effect sizes18 we label this heterogeneity statistic, QSNP. QSNP is a 2-distributed test 
statistic with larger values indexing a violation of the null hypothesis that the SNP acts entirely through 
the common factor(s). 
 
Validation via Simulation 
Recovery of True Model and Population Parameters. We performed 100 runs of Genomic SEM on 
raw individual-level genotype data for which we simulated multivariate phenotypic data to conform to a 
single genetic factor model (a latent trait that partially causes 5 observed outcomes). Across the 100 
simulations Genomic SEM estimates closely matched the parameters specified in the generating 
population (Supplementary Fig. 1). Model SEs also closely matched the standard deviations of parameter 
estimates. We also compared fit statistics (CFI, AIC, and model 2) for the correctly specified common 
factor model and two deliberately misspecified models: (i) a model in which all indicators were 
constrained to have the same factor loading, and (ii) a model for which the loading of the third indicator 
was set to 0. As expected, results indicated that the common factor model matching the generating 
population was favored ≥ 99% of the time across model fit indices (Supplementary Fig. 2). 
 
Simulation of Partial Sample Overlap. One major benefit of Genomic SEM is that summary statistics can 
be used from samples with unknown degrees of sample overlap. We performed a simulation in order to 
verify that the inclusion of data from overlapping samples does not bias Genomic SEM parameter 
estimates or their standard errors. We simulated data for a single quantitative phenotype in 100,000 
participants, and subsequently split the sample into three subsamples of 60,000 participants each (with 
~66% pairwise overlap between the subsamples). We submitted each of the three subsamples to an 
independent GWAS, and used the three resulting sets of summary statistics as input for a Genomic SEM 
model, in which we specified the phenotype from each individual set of summary statistics as a different 
indicator of a common factor, onto which a SNP effect was specified. If sample overlap is not 
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appropriately accounted for, data are incorrectly treated as deriving from 180,000 participants (as opposed 
to 100,000 total participants), and we would expect the Z statistics for the SNP effects to be upwardly 
biased relative to those from a univariate GWAS applied directly to the single phenotype in the 100,000 
participants. As expected, we observed no such bias. A linear regression of estimates from the Genomic 
SEM model from the three overlapping samples of 60,000 participants each predicting univariate GWAS 
Z statistics in the complete sample of 100,000 participants revealed near perfect correspondence 
(unstandardized slope = 1.003, intercept = -.003). 
 
Confirmatory Factor Analysis of Genetic Covariance Matrices 
We provide two examples of confirmatory factor analysis (CFA) using Genomic SEM. In our first 
example, we fit a genetic factor model to psychiatric case-control traits. Recent findings indicate that the 
comorbidity across psychiatric disorders is captured by a latent, general psychopathology factor that is 
commonly known as the p-factor and is widely supported based on previous results.19-23 We tested for the 
presence of a single common genetic p-factor using Genomic SEM with European-only summary 
statistics for schizophrenia, bipolar disorder, major depressive disorder (MDD), post-traumatic stress 
disorder (PTSD), and anxiety (Table S1 for phenotypes and sample sizes). Model fit was adequate (2[5] 
= 89.55, AIC = 109.50, CFI = .848, SRMR = .212).1 Results indicated that schizophrenia and bipolar 
disorder loaded the strongest onto the genetic p-factor (Supplementary Fig. 3), a pattern of findings that 
closely replicates prior findings from twin/family studies.21 
In a second example, we tested for the presence of a single common genetic factor of neuroticism 
using summary statistics from 12 item-level indicators from UK Biobank (UKB; Table S1) as estimated 
using the Hail software.24 Model fit was good (2[54] = 4884.10, AIC =4932.11, CFI = .893, SRMR = 
.109). Results indicated strong positive loadings for all indicators (Supplementary Fig. 4). We used this 
single common factor model for both neuroticism and the p-factor when estimating SNP effects for 
discovery under the section SNP Effects, below. 
 
Exploratory Factor Analysis of a Genetic Covariance Matrix 
We provide two examples of how one might use exploratory methods to guide the specification of 
more nuanced factor models beyond a one factor model. In the first example, we submitted the LDSC- 
derived genetic correlation matrix of the 12 neuroticism items in UKB to exploratory factor analysis 
(EFA). The two- and three-factor solutions yielded interpretable factor loading patterns (Online 
 
1 For large samples, model 2 may be significant even when discrepancies between the model-implied genetic 
covariance matrix and the empirical LDSC-derived genetic variance matrix are trivial. Model 2 may be more useful 
as a means of comparing nested models than assessing absolute model fit. 
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Supplement). Based on these initial EFA results, follow-up CFAs (Supplementary Fig. 5) were specified 
using Genomic SEM (standardized loadings > .4 were retained; Table S2). The two-factor solution 
(2[53] = 2758.18, AIC = 2808.18, CFI = .940, SRMR = .077) and three-factor solution (2[51] = 
1879.31, AIC = 1933.31, CFI = .959, SRMR = .057) both provided excellent fit to the data and exceeded 
the fit of the single, common factor model. Consistent with the superior model fit indices for the two- and 
three-factor solutions, only 28 and 20 of the 69 QSNP hits from the single common factor model (described 
in further detail, under the SNP Effects section, below) continued to surpass genome-wide significance 
for the two- and three-factor models, respectively (Supplementary Fig. 6; Table S3). In addition, a GWAS 
of all HapMap3 SNPs for the two- and three-factor models revealed the average size of QSNP across all 
SNPs was largest for the common factor (2[1] = 1.68), followed by the two-factor (2[1] = 1.64), and 
three-factor model (2[1] = 1.51). Thus, heterogeneity indices of individual SNP effects in the GWAS 
data agree with fit statistics indexing the correspondence between the Genomic SEM-implied genetic 
covariance matrix and the empirical (LDSC-derived) covariance matrix, with both favoring the three- 
factor model of neuroticism. 
In the second example, EFA was applied to the LDSC-derived genetic correlation matrix for nine 
anthropometric traits from the EGG and GIANT consortia (Table S4). EFA results indicated that two 
factors explained 61% of the total genetic variance. Moreover, a heatmap of the genetic correlation matrix 
suggests two primary factors that index overweight and early life-growth phenotypes (Supplementary Fig. 
7). A follow-up CFA (Supplementary Fig. 8) within Genomic SEM was specified based on the EFA 
parameter estimates (standardized loadings > .25 were retained). The CFA showed good fit to the data 
(2[25] = 12994.71, AIC = 13034.71, CFI = .962, SRMR = .092). Results indicated highly significant 
loadings, and a small correlation between the two factors (rg = .10, SE = .03, p < .001). This indicates that 
early life physical growth is modestly associated with later life obesity traits via genetic pathways. 
 
Genetic Multivariable Regression (Replicating GWIS) 
Nieuwboer et al. (2016)25 use summary statistics for educational achievement (EA)26 and both 
schizophrenia and bipolar disorder27 to determine if genetic correlations with EA are driven by variation 
specific to either disorder. EA is genetically correlated with schizophrenia (rg = .148, SE = .050, p = .003) 
and bipolar disorder (rg = .273, SE = .067, p < .001). Using a method called genome-wide inferred 
statistics (GWIS), they find that the correlation of EA with schizophrenia unique of bipolar is small (rg = 
.040, SE = .082, p = .627), whereas the genetic correlation between bipolar unique of schizophrenia and 
EA is far less attenuated (rg = .218, SE = .102, p = .032). We use Genomic SEM with the aim of 
replicating these results using a conceptually similar, but statistically distinct, framework. We present this 
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example to demonstrate that Genomic SEM is not limited to factor analytic models, but can be used to 
construct and test an array of hypotheses using a general SEM approach. 
Using the same univariate GWAS summary statistics employed in the original application of 
GWIS, we used Genomic SEM to fit a structural multivariable regression model in which the genetic 
component of EA was simultaneously regressed onto the genetic components of schizophrenia and 
bipolar disorder. Fit indices are not reported as this was a fully saturated model (i.e., df = 0). Results 
confirmed the findings by Nieuwboer et al. (2016);25 the conditional standardized association between 
schizophrenia and EA was quite small (bg = -.016, SE = .096, p = .867), whereas there was a strong 
conditional standardized association between bipolar disorder and EA (bg = .283, SE = .113, p = .012; 
Supplementary Fig. 9). 
 
SNP Effects 
Common Factor Models. A powerful application of Genomic SEM is to include individual SNP effects in 
both the genetic covariance matrix and the sampling covariance matrix, in order to estimate the effect of a 
given SNP on the latent genetic factor(s). If the summary statistics are composed of M different SNPs, 
then M models are estimated to obtain genome-wide summary statistics for the latent factor. As an 
example of Genomic SEM used for multivariate GWAS, we incorporated SNP effects into the p-factor 
and neuroticism models presented above. LD-independent hits are defined below as r2 < .1 in a 500Kb 
window, with the exception of a 1Mb window for chromosomes 6 and 8. 128 independent loci were 
genome-wide significant for the p-factor (p < 5 × 10−8; Supplementary Figs. 10-11 for QQ-plot and 
Manhattan plot of univariate estimates; Supplementary Fig. 12, Figs. 1 and 2 for factor model and 
Manhattan plots). Of the 128 loci, 27 independent loci were not previously identified in any of the 
contributing univariate GWASs (Table 1, Table S5). Of these 27 loci, five loci were identified as either 
genome-wide significant or suggestive of significance (p < 1 × 10−5) in a separate, previously published 
GWAS of one of the five traits. 118 loci were genome-wide significant for neuroticism, with 38 loci not 
identified in the univariate item-level GWASs (Table S6). Plots of item-level effects for individual SNPs 
revealed high consistency in magnitude and direction for SNPs identified as genome-wide significant for 
the common factors (Supplementary Fig. 13). Although there is early lift-off in the QQ-plots for both 
common factors, LDSC analyses of the summary statistics produced by Genomic SEM indicated that 
results were not due to uncontrolled inflation for either the p-factor (intercept = .987, SE = .014) or 
neuroticism (intercept = .997, SE = .001). 
 
General Trends. Mean 2 statistics were higher for the Genomic SEM-derived summary statistics of 
common factors relative to univariate indicators (Table 1). It is important to note here that, whereas 
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Genomic SEM may boost power in many cases, this is not the primary purpose of the method. Rather, it 
is to identify the relationship between SNPs and observed phenotypes as meditated through a user- 
specified model and to concurrently evaluate the construct validity of said model. Inspecting the 
distribution of univariate p-values for the newly identified SNPs for the general factors indicated that 
these SNPs were generally characterized by relatively low p-values, albeit not low enough to cross the 
genome-wide significance threshold for any individual phenotype (Supplementary Figs. 14-15). 
 
QSNP Results. Results revealed 1 and 69 independent QSNP loci for the p-factor and neuroticism, 
respectively (Fig. 2; Supplementary Fig. 16 for QQ-plot). For neuroticism, significant QSNP estimates were 
obtained for SNPs that were highly significant for some traits but not others (Table S7; Supplementary 
Fig. 17). The association between p-values for SNP effects and QSNP estimates were minimal 
(Supplementary Fig. 18). Comparing the QSNP estimates for SNPs identified as significant for only the p- 
factor or neuroticism relative to SNPs identified as significant for one of the indicators, but not the 
common factor, indicated that the latter group of SNPs were characterized, as would be expected, by 
larger QSNP estimates (i.e., greater heterogeneity in individual effects; Supplementary Fig. 19). Intercepts 
from LDSC analyses of the QSNP statistics also indicated that results for the heterogeneity index were not 
attributable to inflation (p-factor: intercept = .978, SE = .009; neuroticism: intercept = .963, SE = .009). 
Slopes from the same LDSC analyses further indicated genetic signal in heterogeneity (p-factor: Z = 
13.65, p-value = 6.68E-42; neuroticism: Z = 30.23, p-value = 9.98E-201). 
 
Comparison to MTAG. Existing multivariate methods use summary statistics of genetically correlated 
phenotypes to boost power for discovery and prediction for a particular trait.11,28,29 We note that while this 
is only one application of Genomic SEM, a Genomic SEM common factor GWAS approach has already 
been shown by an independent research group to perform comparably to existing multivariate approaches 
for out-of-sample prediction.30 Moreover, as a flexible modeling framework, Genomic SEM may 
encompass other multivariate approaches. As a specific example, we show mathematically that Genomic 
SEM can be specified to satisfy the same moment conditions as multi-trait analysis of GWAS (MTAG11; 
see Online Supplement). Simulation results also revealed near perfect correspondence from a linear 
regression in which Z statistics from MTAG were used to predict those from a Genomic SEM specified to 
satisfy the MTAG moment conditions (Supplementary Fig. 20; unstandardized slope = .999, intercept = 
2.65E-4). 
 
Performance in Empirical Data under Controlled Missingness. We contrast estimates obtained from the 
common factor model of neuroticism described above with estimates for a GWAS with an imposed 
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missing structure. We first transformed the binary scale neuroticism items into a smaller number of 
quantitative scores. To do so, we created three parcels of neuroticism items consisting of 4 items each 
with scores ranging from 0 to 4, at which point it is appropriate to treat the parcel as continuous.31 Parcels 
were constructed based on the same EFA results described above and mirrored the composition of the 
three-factor model, with the exception that the irritability item was included with parcel 2 so as to have an 
equal distribution of 4 items per parcel. Of the 300,000 participants, 100,000 non-overlapping participants 
were removed from two of the three parcels for missing data models. The best powered results (indexed 
by mean 2 values) were for Genomic SEM of the individual neuroticism items presented above, 
indicating that construction of composite indices via averaging, though convenient, removes multivariate 
information that can otherwise be retained with Genomic SEM (Table S8). Genomic SEM analyses that 
incorporated supplemental information from parcels containing imposed missing data consistently 
outperformed GWAS of individual parcels with complete data, and performed nearly as well as analyses 
of complete data across all three parcels. Thus, inclusion of summary data from genetically correlated, 
phenotypes in Genomic SEM may boost power relative GWAS of the individual phenotypes, even when 
there is high sample overlap and sample sizes are uneven across phenotypes. 
 
Parcel Comparison of QSNP. Using the three constructed parcels without any missing data, the distribution 
of p-values was compared across SNPs with high (p < 5e-8) and low (p > 5e-3) QSNP estimates from the 
item-level Genomic SEM analysis of neuroticism for SNPs that were genome-wide significant in at least 
one of the parcels. These results indicated that, for SNPs with a higher QSNP for the common factor, there 
was more discordance of effect sizes among three lower-order factors relative to SNPs that produced 
lower heterogeneity estimates (Supplementary Fig. 21). The average difference between the highest and 
lowest –log10 p-values was 10.56 and 4.96 for high and low QSNP, respectively. This suggests that QSNP is 
appropriately indexing discordance in SNP level effects across genetically correlated indicators. 
 
Polygenic Prediction. We re-estimated the p-factor model using the summary statistics from the SCZ and 
MDD GWASs that did not overlap with the UKB dataset, in order to predict psychiatric symptoms in 
UKB (Supplementary Fig. 22 for phenotypic model). In order to produce a reliable set of targets for 
polygenic prediction, and to focus our analyses on construct validation, latent factors of psychiatric 
symptoms were specified as the out-of-sample targets. We compared the magnitude of out-of-sample- 
prediction for the p-factor PGSs predicting the phenotypic p-factor and factors of individual psychiatric 
domains relative to the prediction using PGSs derived from univariate summary statistics (Fig. 3, Table 
S9). The PGSs for the genetic p-factor predicted more variance in depression, psychotic experiences, 
mania, anxiety, PTSD and a phenotypic p-factor than any univariate PGS. 
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For neuroticism, univariate PGSs were constructed in data from the Generation Scotland study 
using summary statistics for the 12 neuroticism items, the Genomic SEM factor of items, the three 
neuroticism parcels, the Genomic SEM factor of parcels, and the neuroticism sum score. We used PGSs 
to predict a sum score composed of the same neuroticism items administered in UKB. We also calculated 
mean 2 values for each of these summary statistics, which we used to infer their relative power. Of all 
the summary statistics considered, summary statistics derived from a Genomic SEM analysis of a 
common factor of the neuroticism items produced both the largest mean 2 in the summary statistics and 
predicted the greatest variance in the out-of-sample phenotype (Fig. 4). In both cases, the superior 
performance of Genomic SEM analysis of the common factor of items relative to the sum score of the 
items is likely, in part, a reflection of the fact that the sum score in UKB was created using listwise 
deletion, resulting in a reduced sample size of 274,008. Conversely, Genomic SEM uses all available 
information from neuroticism items, with sample sizes of ~325,000 each. In more severe cases of sample 
non-overlap, we would expect even larger power benefits of Genomic SEM-derived summary statistics 
relative to individual items or sum scores. Indeed, in instances of minimal sample overlap, it is not 
possible to compute sum scores, but Genomic SEM can still be used to integrate data across phenotypes. 
 
Biological Annotation. The biological function of the SNPs related to the p-factor and neuroticism was 
examined using DEPICT.32 Table 1 presents the number of enriched gene sets, prioritized genes, and 
enriched tissues and cell types across the univariate statistics and common factors (Supplementary Tables 
S10-S18 for detailed output). Common factors produced far more informative results than the individual 
indicators. As expected, all of the tissue enrichment for the common factors was identified in the nervous 
system (Fig. 5). Neuroticism prioritized genes indicated a central role of synaptic activity (e.g., STX1B, 
NR4A2, PCLO), including glutamatergic neurotransmission (GRM3). The p-factor gene sets were largely 
characterized by communication between neurons (e.g., “dendrite development”, “dendritic spine”, 
“abnormal excitatory postsynaptic potential”). Biological annotation of QSNP statistics for neuroticism 
indicated that genes within the 69 loci related to neuroticism, but not through a single factor, include: 
GRIA1, a glutamate receptor subunit (i.e. involved in signaling is excitatory neurons) which has 
previously been related to schizophrenia,33 chronotype,34 and autism;35 and PCDH17, a gene involved in 
cellular connections in the brain that has been related to intelligence.36 
 
General Guidelines 
When implementing Genomic SEM, users should be aware of the limitations and assumptions of 
the method. First, because Genomic SEM is a method for modeling genetic covariance matrices, it relies 
on the same assumptions as the method used to estimate genetic covariances, and best practices for 
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implementing such methods should be followed. For example, when LDSC is used to construct the 
genetic covariance matrix, SNPs should not first be pruned for linkage disequilibrium, and summary 
statistics for different phenotypes should be obtained from ethnically homogeneous samples of similar 
ancestral backgrounds.4 With respect to selecting between competing models, users should take into 
account a variety of both absolute fit (e.g. SRMR and model 2) and relative fit indices (e.g. AIC and 2 
difference). We provide general standards for absolute model fit in the Method section. Finally, a formal 
power analysis should take into account specific characteristics of the summary data, the genetic 
architecture of the phenotypes, and the model to be specified. This can typically be achieved with 
simulation. Generally speaking, we would expect power to detect SNP effects on a common genetic 
factor to be high when the phenotypes composing the factor have high heritabilities, and high genetic 
correlations, sample sizes are larger and sample overlap is lower. That said, we still expect some power 
benefits relative to univariate GWAS when the constituent phenotypes are only moderately heritable 
and/or moderately genetically correlated and/or sample overlap is high. The choice of included summary 
statistics, phenotypes, and model(s) will of course depend on the researcher’s objectives and the model(s) 
to be specified. 
 
Discussion 
Applications of genome-wide methods to data from large scale population-based samples have 
uncovered clear evidence of pervasive shared genetic architecture across social, behavioral, and 
psychiatric traits. Genomic SEM is a novel method for modeling the multivariate genetic architecture of 
constellations of genetically correlated traits and incorporating genetic covariance structure into 
multivariate GWAS discovery. In contrast to methods9 that model phenotypic, rather than genetic 
covariance structure, and rely on raw data, Genomic SEM employs summary GWAS data to model 
genetic covariance structure. Genomic SEM is computationally efficient, accounts for potentially 
unknown degrees of sample overlap, and allows for flexible specification of covariance structure, such 
that several broad classes of structured covariance models can be applied. The Genomic SEM approach 
shares benefits of some existing approaches11 for boosting power by combining information across 
genetically correlated phenotypes. However, Genomic SEM uniquely allows one to compare different 
hypothesized genetic covariance architectures and to incorporate such architectures into multivariate 
discovery. Importantly, shared genetic liabilities across phenotypes can be explicitly modeled as factors 
that may be treated as broad genetic risk factors with equally broad downstream consequences. 
Multivariate genetic methods have existed for decades in the twin literature, with Martin and Eaves 
(1977)37 providing a framework for fitting structural equation models of genetic and environmental 
variance components in multivariate twin data. Genomic SEM can be used to reproduce multivariate 
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genetic models from the existing twin literature using GWAS summary data from unrelated individuals. 
Moreover, Genomic SEM offers new promise as a method that allows for the estimation and modeling of 
genetic covariance even among phenotypes for which phenotypic covariance cannot be estimated. 
Genomic SEM is not the only method for multivariate GWAS. Other methods, such as MTAG,11 
SHom/SHet,38 metaUSTAT,39 min-P,40 and TATES29 allow researchers to perform multivariate meta- 
analyses based solely on summary data. The methods can generally be divided into 2 distinct classes: 
methods which aggregate test statistics or effect sizes based on a model (Genomic SEM, SHom and 
MTAG) and those which efficiently select from the univariate p-values while taking care not to inflate 
Type-I error (min-P, TATES, and SHet). As we show with respect to MTAG, some models can be fit in 
the context of Genomic SEM. It is also conceivable that the approach of efficiently selecting the 
minimum p-value from a set of analyses while maintaining proper Type-I error control could be 
integrated within Genomic SEM. For instance, whereas TATES is currently applied to select the 
minimum p-value from a series of univariate analyses of correlated traits, the same analysis could be used 
to select the minimum p-value from a series of Genomic SEM models. With respect to multivariate 
GWAS, we argue the choices available are not mutually exclusive. With respect to other multivariate 
analyses of genome-wide data that go beyond multivariate GWAS discovery, the major alternatives to 
Genomic SEM that we are aware of are GWIS25 and GW-SEM.9 When considering linear relationships 
between traits, Genomic SEM is more flexible and user friendly than GWIS, and GW-SEM requires 
access to phenotypic data, which is a substantial limitation for many applications. 
In contrast to approaches that assume homogeneity of effects across SNPs, such as MTAG,11 
Genomic SEM includes diagnostic indices for its key assumptions, including a test for heterogeneity, 
QSNP, that can be applied at the level of the individual SNPs. This offers the unique ability to identify 
SNPs that confer specific risk to individual phenotypes, symptoms, or indicators. This question may be of 
particular interest as the large degrees of genetic overlap identified across phenotypes (e.g., bipolar 
disorder and schizophrenia) beg the question: what are the genetic causes of phenotypic divergence? 
Whereas previous GWASs have combined items tapping genetically-related phenotypes into a single 
score, or even combined cases with different diagnoses to obtain a shared genetic effect, Genomic SEM 
allows researchers to interrogate shared genetic effects between diagnoses or indicators, while 
concurrently testing for causes of divergence (i.e., loci that are related only to a specific phenotype, or 
subset of phenotypes, but not the more general liability). In the context of neuroticism, for example, we 
identified 69 loci that were significantly involved in one manifestation of neuroticism but whose effects 
were not shared through a common factor, offering novel evidence of biological heterogeneity in the 
etiology of a construct long thought to be unidimensional. Because Genomic SEM relies only on GWAS 
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summary data, it can be applied to a broad spectrum of traits, including social, economic, cognitive, and 
psychiatric outcomes. 
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Method 
Overview of Genomic SEM 
In Genomic SEM, the user specifies a multivariate system of regression and covariance 
associations involving the genetic components of phenotypes with one another and/or more general latent 
factors. These associations are represented by parameters that may be fixed or freely estimated, so long as 
the model is statistically identified (e.g., the number of freely estimated parameters does not exceed the 
number of nonredundant elements in the genetic covariance matrix being modeled). A set of parameters 
( ) is estimated such that the fit function indexing the discrepancy between the model-implied 
covariance matrix ∑(θ) and the empirical covariance matrix S is minimized. Model fit is considered good 
when ∑(θ) closely approximates S. 
 
Form of Structured Covariance Models 
Genomic SEM provides substantial user flexibility with respect to the particular SEM that is 
specified to produce the model-implied covariance matrix ∑(θ) that approximates the empirical 
covariance matrix, S. SEMs can be partitioned into two sets of equations, one describing the measurement 
model, and the other describing the structural model. In the measurement model, the genetic components 
of k “indicator” phenotypes are described as linear functions of a smaller set of m (continuous) latent 
variables, y= Λη + ε . In this equation, y is a k  1 vector of indicators, ε is a k  1 vector of residuals, η 
is an m 1 vector of latent variables, and  is a k  m matrix of factor loadings, i.e. regressions relating 
the latent variables to the set of indicators. In a typical application of Genomic SEM, each indicator is a 
function of exactly one of the latent variables (though this so-called “simple structure” restriction may be 
relaxed). In a confirmatory factor analysis (CFA) model, only the measurement model is specified, and 
the set of latent variables are allowed to freely covary. Thus, the model-implied covariance matrix of a 
CFA is Σ  = ΛΨΛ+Θ , where Ψ is an m × m latent variable covariance matrix and Θ is a k  k 
matrix of covariances among the residuals, ε. Typically, Θ is diagonal, which implies that indicators are 
mutually independent conditional on the set of latent variables. That constraint may be relaxed such that 
select pairs of indicators are allowed to covary over and above their associations via the latent variable 
structure (i.e., residual covariances are allowed). CFA models are typically used to assess the strength of 
relations between sets of indicators and their respective underlying latent variables, as well as to assess 
the fit of a measurement model to data. A well-fitting CFA model implies that the latent variable structure 
is able to account for the observed covariances among a set of indicator variables. 
When a theory aims to explain associations among latent variables, a structural model can be 
added to the measurement model to produce a full SEM. The structural model of a SEM relates latent 
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variables to each other via directed regression coefficients. It can be written in matrix notation as 
η = Βη + ζ, where B is an m × m matrix of regression coefficients that relate latent variables to each 
other and ζ is an m 1 vector of latent variable residuals. The model implied covariance matrix of 
observed variables is  Σ  = ΛI - B
-1 
Ψ I - B
-1 
Λ+Θ, where  I  is an  k  k  identity matrix.41 
Thus, in a full SEM, the empirical matrix is represented by a set of parameters that relate observed 
variables to latent variables, and relate latent variables to each other in a series of linear equations. 
 
Path Diagrams 
SEMs can be represented graphically as path diagrams representing regression and covariance 
relations among variables.42 In path diagrams, observed variables are represented as squares and 
unobserved (i.e., latent) variables are represented as circles. Regressions relationships between variables 
are represented as one-headed arrows pointing from the independent variable to the dependent variable. 
Covariance relationships between variables are represented as two-headed arrows linking the two 
variables. The variance of a variable (i.e., the covariance between a variable and itself), is represented as a 
two-headed arrow connecting the variable to itself. In Genomic SEM, we represent the genetic component 
of each phenotype with a circle, as the genetic component is a latent variable that is not directly measured, 
but is inferred from LDSC (it is the phenotype itself that is observed in the raw data that is used to 
produce the summary statistics). SNPs are directly measured, and are therefore represented as squares. 
When all elements in a SEM are represented in a path diagram, the diagram contains the full system of 
algebraic equations needed to estimate the full set of SEM parameters, , and produce the model-implied 
covariance matrix, ∑(θ). 
 
Stage 1 Estimation 
In Stage 1, the empirical genetic covariance matrix (SLDSC) and its associated sampling covariance 
matrix (VSLDSC) are estimated using our multivariable extension of LDSC. SLDSC is a  k  k symmetric 
matrix with SNP heritabilities on the diagonal and genetic covariances (σgi,gj) between phenotypes i and j 
off the diagonal. The genetic covariance between phenotypes i and j can be computed as the genetic 
correlation scaled relative to the total genetic variance of each of the two contributing phenotypes 
(themselves scaled to unit variances), 
gi, gj 
 r
gi, gj 
 . Thus, the genetic covariance matrix of 
order k has k
*  k k  1 / 2 nonredundant elements. It can be written as: 
h
2 
 h
2
 
i j 
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To produce unbiased SE estimates and test statistics, we require the asymptotic sampling 
covariance matrix, VSLDSC, of the LDSC estimates that is composed of all nonredundant elements in the 
SLDSC  matrix. Thus, it is a symmetric matrix of order k*, with  k
* k *   1 / 2  nonredundant elements. The 
diagonal elements of VSLDSC  are sampling variances, that is, squared SEs of the elements in SLDSC. The off- 
diagonal elements of VSLDSC  are sampling covariances that indicate the extent to which the sampling 
distributions of the variance and covariance estimates in SLDSC covary with one another, as would be 
expected when there is overlap among the samples from which the terms are estimated. This VSLDSC    matrix 
can be written as: 
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The diagonal elements of VSLDSC  are estimated using a jackknife resampling procedure in the 
bivariate version of LDSC that is currently available by its original developers.4,43 The LDSC function 
introduced in the GenomicSEM software package expands the jackknife procedure to the multivariable 
context in order to produce sampling covariances (which index dependencies among estimation errors) 
among the elements of SLDSC, needed to populate the off-diagonal elements of VSLDSC. 
 
Incorporation of Individual SNP Effects 
Several steps are needed to incorporate individual SNP effects into Genomic SEM. The first step 
requires that the inputted genetic covariance matrix be expanded to include covariances between the SNP 
h 

   

 

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and each of the phenotypes, g1 through gk, by appending a vector of SNP-phenotype covariances (SSNP) to 
SLDSC: 
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The sampling covariance matrix, VSFull, associated with this expanded SFull  covariance matrix 
includes a number of components. One block of this VSFull  matrix, VSLDSC, contains the sampling variances 
and sampling covariances of the latent genetic variances (SNP heritabilities) and genetic covariances, 
which are obtained from the multivariable LDSC approach introduced above. A second block of the VSFull 
matrix, VSSNP, is composed of the sampling covariance matrix of the SNP effects on the phenotypes. The 
SNP variance (derived from reference panel data) is treated as fixed, and its sampling variance and 
sampling covariance with all other terms are fixed to 0 (or to a very small value to facilitate 
computational tractability). The sampling covariances of the SNP-genotype covariances with one another 
are obtained using cross-trait LDSC intercepts (which represent sampling correlations weighted by 
sample overlap) after being rescaled relative to the sampling variances of the respective SNP-genotype 
covariances.11,44 A final block of the VSFull  matrix represents the sampling covariance of the SNP-genotype 
covariances with the genetic variances and genetic covariances. These are fixed to 0, as sampling 
variation of the SNP-genotype covariance is expected to be independent of the test statistics of all LD 
blocks except the one it occupies. Because the sampling variance of the heritabilities and genetic 
correlations derive from sampling variability in the test statistics within all of the LD blocks, their 
sampling covariances with a single SNP effect is expected to approach 0. In sum, the VSFull  matrix can be 
written in compact form as: 
V  
VSSNP 
SFull 
  
0 V 

 SLDSC  


Stage 2 Estimation 
In Stage 2, the genetic covariance matrix obtained in the previous stage, S, is used to estimate the 
parameters in a SEM. In this stage, we allow for both weighted least squares (WLS) and normal theory 
maximum likelihood (ML) estimators. WLS does not strictly require positive definite S and VS matrices, 

h 
h 

 
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but may still benefit from positive definiteness during optimization. ML estimation requires both S and VS 
to be positive definite. The GenomicSEM software package therefore smooths S and VS to the nearest 
positive definite matrices prior to Stage 2 estimation using the R function nearPD.45 
The fit function minimized in the diagonally weighted version of WLS estimation that is standard 
in the GenomicSEM software package is the following: 
F    s    D1 s    , 
WLS S 
 
where S and Σ(θ) have been half-vectorized to produce s and σ(θ) respectively, and DS is VS with its off- 
diagonal elements set to 0. We choose the diagonally weighted version of WLS because it is more 
tractable to implement for large (highly multivariate) matrices and is more stable than fully weighted 
WLS in finite samples.46,47 
ML estimation proceeds by minimizing the following fit function: 
F
ML    log    log S  trS1   k 
where   is the covariance matrix implied by the set of parameter estimates. Note that, while the 
formulation of the ML fit function does not explicitly include a weight matrix, it is asymptotically 
equivalent to a more general formulation that is identical to the WLS fit function, with 
.5D 1  1  D , where Dk is the duplication matrix of order k, in place of DS . Thus, the 
difference between ML and WLS estimation can be construed as a difference in weight matrices only. A 
comparison between ML and WLS results can be found in the Online Supplement (Supplementary Figs. 
23-27, Table S19). 
WLS estimation more heavily prioritizes reducing misfit in those cells in the S matrix that are 
estimated with greater precision. This has the desirable property of potentially decreasing sampling 
variance of the Genomic SEM parameter estimates, which may boost power for SNP discovery and 
increase polygenic prediction. However, because the precision of cells in the S matrix is contingent upon 
the sample sizes for the contributing univariate GWASs, WLS may produce a solution that is dominated 
by the patterns of association involving the most well powered GWASs, and contain substantial local 
misfit in cells of S that are informed by lower powered GWASs. In other words, WLS relative to ML may 
more heavily prioritize minimizing sampling variance of the parameter estimates in the so-called variance 
bias tradeoff.48 We expect that this will only occur when the model is overidentified (i.e., df > 0), such 
that exact fit cannot be obtained, and that divergence in WLS and ML estimates will be most pronounced 
when there is lower sample overlap and the contributing univariate GWASs differ substantially in power. 
ML estimation may be preferred when the goal is to most evenly weight the contribution of the univariate 
sample statistics. 
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Both WLS and ML fit functions will produce consistent estimates of the model parameters when 
the model is true.47 However, the “naïve” SEs and fit statistic produced in Stage 2 estimation will be 
incorrect, because neither estimator uses the full VS matrix in estimation. Thus, robust corrections must be 
applied to produce consistent estimates of SEs and test statistics. The correct sampling covariance matrix 
of the Stage Two, Genomic SEM parameter estimates (i.e., V ) can be obtained using a sandwich 
correction:13,47 
V    ˆ 1ˆ 
1  
ˆ 1V 1ˆ ˆ 1ˆ 
1
 
 
where   
LD( ) 
 



 
is the matrix of model derivatives evaluated at the parameter estimates ,  is the 
naïve Stage 2 weight matrix that takes its form depending on the estimation method used (WLS or ML), 
and VS is the sampling covariance matrix of S obtained using multivariable LDSC. 
It may not always be possible to obtain the full sampling covariance matrix, VS. For example, for 
highly sensitive data only the matrix S and the SEs of its elements may be available (i.e., the diagonal of 
VS). However, we note that when there is low sample overlap across the GWASs for each phenotype, off- 
diagonal elements of the sampling covariance matrix are small and pragmatically ignorable. Moreover, in 
other contexts with complete sample overlap, SE inflation of the SEM parameters estimated using 
diagonally-weighted versions of WLS has been estimated to be less than 8%9 without robustness 
corrections, and nil with robustness corrections.47 
 
Standardization and Scaling of Summary Statistics for Multivariate GWAS 
Typically, GWAS summary statistics for quantitative phenotypes are not reported in terms of 
covariances, but are reported as ordinary least squared (OLS) unstandardized regression coefficients, with 
the phenotypes standardized prior to analyses (i.e., the coefficients are standardized with respect to the 
outcome, but not the predictor). In order to transform these partially standardized regression coefficient 
(bSNP,P) of a SNP effect on phenotype P to a covariance, we multiply by the variance of scores on the 
SNP. The variance ( 2 ) of scores (0, 1, 2) of a biallelic autosomal SNP is estimated as 2pq, assuming 
 
Hardy-Weinberg-Equilibrium, where p = the minor allele frequency (MAF) and q = 1-MAF, with the 
MAF typically obtained from a reference sample. As the latent genetic factors estimated in LDSC are 
scaled relative to unit-variance scaled phenotypes (by virtue of the SNP heritability estimates being 
placed on the diagonal of S), no further scaling is needed to transform this SNP-phenotype covariance 
into a SNP-genotype covariance. 
Genomic SEM 21 
 
2 
SNP 
 blogit 2 
SNP,P 
 
2 
3 
 
 
When OLS regression coefficients and standard errors are provided from an analysis in which the 
phenotype has not been standardized prior to analyses, or only Z statistics or p-values (for which Z 
statistics can be readily obtained) are provided, the partially standardized regression coefficients and their 
standard errors can be obtained as Z 
b* 
SNP ,P , b
 
 
 
Z 
, and SE  
b
SNP,P 
, where b
*
 
 
SE * 
b
SNP ,P 
SNP,P bSNP ,P Z SNP ,P 
is equal to the regression coefficient for the OLS GWAS of the unstandardized phenotype. These derived 
partially standardized coefficients are then transformed into covariances by multiplying by the variance of 
scores on the SNP, as per above. 
When the GWAS summary statistics are reported for logistic regressions of liabilities for 
categorical outcomes (e.g. case/control status) on the SNP, the logistic regression coefficients can be 
transformed into covariances as above, by multiplying by the SNP variances. However, it is appropriate to 
further transform the coefficients and their SEs such that they are scaled relative to unit-variance scaled 
 
liability. This can be achieved by dividing by , as a logistic regression model 
 
 2 implies a residual variance of . If GWAS summary statistics are reported for odds ratios (ORs), they 
3 
can be transformed to logistic regression coefficients by taking their natural logarithm. Standard errors for 
the logistic regression coefficient are obtained as SEOR/OR. The derived logistic coefficients and their SEs 
should further be transformed such that they are scaled relative to unit-variance scaled phenotypes, as per 
above. Note that when the outcomes are categorical, the liability scale heritabilities and genetic 
covariances from multivariable LDSC (and not what are referred to as the “observed scale” heritabilities 
and genetic covariances) should be used to populate the S matrix. This has the desirable property of both 
modeling the continuous scale of risk in the population and providing estimates that are independent of 
the observed prevalence of the categorical outcomes. 
On occasion, summary statistics will be provided from OLS GWASs of categorical outcomes 
(e.g., case/control status). Such an analysis is sometimes referred to as a linear probability model, as it 
(incorrectly) assumes that the association between the predictor and the probability of being in the 
comparison (e.g. case) group relative to the reference (e.g. control) group is linear. Parameters from the 
linear probability model are dependent not only on the strength of the association between the SNP and 
the continuous underlying liability, but also on the MAF and the proportion of comparison group 
members (cases) in the sample. Thus, parameters from the linear probability model cannot be used 
directly in Genomic SEM. However, particularly in the case of complex traits, for which the effect sizes 
for individual SNPs are small, results from the linear probability model can be used to very closely 
N2 
SNP 
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approximate logistic regression coefficients and SEs that are amenable for use in Genomic SEM.49 This 
b** 
approximation can be obtained as Z SNP ,P , 
SE ** 
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is equal to the regression coefficient from the linear probability 
b
SNP ,P Z SNP ,P 
model, blogit
* 
is the expected logistic regression coefficient that is derived from the linear probability 
SNP,P 
 
model results, v is equal to the proportion of cases in the sample, and  2 
 
is the variance of the SNP, 
 
computed from its MAF obtained from a reference sample, as per above. To scale the derived logistic 
coefficient such that it is scaled relative to unit-variance scaled liability, the coefficient should be divided 
 
by . Lloyd-Jones et al. (2018)49 report that in a real data analysis of UKB 
 
data, the exponentiated regression coefficient (i.e., the odds ratio) obtained directly from a logistic 
regression-based GWAS and that derived from the linear probability model-based GWAS was nearly 
perfect (R2 > 98%, slope ≈ 1). We have verified this nearly perfect correspondence in our own simulations 
(Supplemental Fig. 28). 
Even within samples of the same ethnicity, there is likely to be discrepancies between the MAFs 
of a reference sample and the sample that GWAS summary statistics were generated from. However, 
some summary statistics may not include allele frequencies, and using the same reference panel for 
standardization across phenotypes has the desirable property of maintaining consistency across summary 
statistics. To examine the effect of this decision, the betas for 30,000 randomly selected SNPs for the 
mood phenotype from UKB were standardized using either sample or reference panel MAF. The 
correlation between the betas was .982, and a linear regression of betas standardized using reference panel 
MAF predicting standardization using sample MAF revealed near perfect correspondence (slope = 1.044, 
intercept = -6.54e-6; Supplemental Fig. 29). 
 
Model Fit Statistics 
Model 2 is an index of exact fit of a SEM. It indexes whether the model-implied genetic 
covariance matrix, Σ(θ), differs from the empirical genetic covariance matrix, S. Model 2 can also be 
used as a relative fit index for comparing nested models. Conventional SEM approaches to indexing 
model 2 are based on formulas that directly incorporate N. Because there is not an N that directly 
corresponds to the genetic covariance matrix that is modelled by Genomic SEM in the same way that N 
typically corresponds to an observed covariance matrix, we derived a formula for estimating model 2 
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that does not require N, but instead incorporates the sampling covariance matrix of the model residuals. 
This is done in two steps. In Step 1, the proposed model (e.g., a common factor model) is estimated. In 
Step 2, all of the Step 1 estimates are fixed, and the residual covariances and residual variances of the 
indicators are freely estimated. Residual variances are estimated in Step 2 by estimating the variances of k 
residual factors defined by the indicators. This provides an estimate of the discrepancy between the model 
implied and observed covariance matrices, R  S    , along with the sampling covariance matrix 
(VR) of R. While the discrepancy between model implied and observed covariance matrices can be 
computed simply by deriving covariance expectations from the Step 1 model and subtracting the observed 
covariance matrix, such an approach would not provide the corresponding VR matrix necessary for the 
calculations below. The VR matrix is expected to be positive semidefinite and, consequently, have no 
negative eigenvalues. Therefore, the VR matrix has the following eigendecomposition: 
VR = (P1 P0) " 
" #
 
% % 
# $  % 
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where P1 is a matrix of principal components (eigenvectors) of VR, and ( is a corresponding diagonal 
matrix consisting of non-zero eigenvalues. P0 reflects the null space of VR. Projecting Ri—a vector of 
residual covariances estimated from the Step 2 Model—onto P1 and adjusting for corresponding 
eigenvalues, we have that: 
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This equation produces a test statistic that is 2 distributed with degrees of freedom (r) equal to the 
difference between the number of nonredundant elements (k*) in the empirical covariance matrix (S) and 
the number of freely estimated parameters in the proposed model. 
The Comparative Fit Index (CFI) is a test of approximate model fit. CFI indexes the extent to 
which the proposed model fits better than a model that allows all phenotypes to be heritable, but assumes 
that they are genetically uncorrelated. The 2 statistic can be used to calculate CFI by calculating a second 
2 statistic for a so-called independence model, i.e. a model that estimates genetic variances of all 
phenotypes but assumes all genetic covariances to be zero, such that ∑(θ) is diagonal. CFI is calculated 
using the formula below,50 with f = 2 – degrees of freedom: 
f(Independence Model) – f(Proposed Model) 
f(Independence Model) 
For the 2 of the independence model, a model is estimated in Step 1 that includes only the variance of the 
indicators and no common factor. In Step 2, these variances are fixed and the covariances among the 
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indicators and variances of k residual factors defined by the indicators are estimated and used to populate 
the same equation above used to calculate the proposed model 2. CFI values theoretically range from 0 
to 1, with higher values indicating good fit. CFI values of .90 and above are typically considered 
acceptable fit, and values of .95 and above are typically considered good model fit.51 When the empirical 
covariance matrix contains a large number of cells that are very close to 0, CFI values may be low, even 
when such cells are approximated well by the model. 
Akaike Information Criterion (AIC) is a relative fit index that balances fit with parsimony, and 
can be used to compare models regardless of whether they are nested. AIC is calculated as: 
AIC = 2 + 2 × fp, 
where fp is the number of free parameters in the model.52 Lower AIC values are considered superior. 
Standardized Room Mean Square Residual (SRMR) is an index of approximate model fit that is 
calculated as the standardized root mean squared difference between the model-implied and observed 
correlations in Σ(θ) and S, respectively.53 Higher SRMR values indicate a larger discrepancy between Σ(θ) 
and S. It is positively-biased, with larger bias resulting when the contributing univariate GWAS samples 
are lower powered. SRMR values below .10 indicate acceptable fit, values less than .05 indicate good fit, 
and a value of 0 indicates perfect fit.54 
We recommend that model fit indices be considered concurrently, as individual indices each have 
their own strengths and limitations. Model 2 is an index of exact fit, with lower values indicating better 
fit. Model 2 may oftentimes be statistically significant, indicating that the model-implied genetic 
covariance matrix significantly differs from the empirical (unrestricted) genetic covariance matrix, even 
when the model-implied covariance matrix very closely approximates the empirical genetic covariance 
matrix. Oftentimes, models that closely, albeit imperfectly approximate the empirical genetic covariance 
matrix may be scientifically and inferentially useful. We thus recommend considering CFI and SRMR 
indices of absolute fit, even when model 2 is significant. We also recommend using indices of relative fit 
to compare competing models of the same data (i.e. different models fit to genetic covariance matrices 
derived from the exact same summary data for the exact same phenotypes). When models are nested, their 
respective 2 values can be subtracted from one another to calculate a 2 difference test, with df equal to 
the difference in df between the two models. This 2 difference test, indexes the extent to which the less 
complex model (i.e. the model with more df) approximates the empirical genetic covariance matrix 
significantly worse than the more complex model (i.e. the model with fewer df). If the 2 difference test is 
significant, the more complex model should be chosen. If the 2 difference test is not significant, the less 
complex model should be chosen, as it is more parsimonious and approximates the empirical genetic 
covariance matrix no worse than the more complex model. Two models are nested when the set of 
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possible model implied covariance matrices from one model is a subset of the set of possible model 
implied covariance matrices of the second model.55 Nesting can typically be confirmed if the less 
restrictive model can be derived from the more restrictive model by dropping or fixing parameters. 
Regardless of whether models are nested, they can be compared on CFI, SRMR, and AIC, so long as the 
same data are being modeled. 
 
Validation of Summary-Based Model Fit Statistics via Simulation. A generating population with a 
common factor model defined by four, five, or six indicators was used to examine the null distribution of 
the newly derived 2 test statistic using a set of 1,000 simulations per model. These simulations did not 
include individual genotypes, and were simulated solely based on a generating factor structure. For the six 
indicator models the standardized factor loadings in the generating population were .42, .64, .22, .59, .19, 
and .64. The four and five indicator models specified the same factor loadings, excluding the last, or last 
two loadings, respectively. Results indicated that the two-step procedure described above produced a test 
statistic equivalent to the 2 statistic calculated by lavaan from the raw data (Supplementary Fig. 30 and 
Table S20). For a 2 distributed test-statistic, the mean of the null sampling distribution should match the 
df of the test. As expected, the distribution of the test-statistic conformed to a 2 distribution with an 
average approaching the df (Supplementary Fig. 31). Calculated CFI values were also highly consistent 
with those observed using the CFI statistic provided by lavaan when using raw data (Supplementary Fig. 
32, Table S20). Calculated AIC values were not contrasted with those obtained using the lavaan package 
in R in the simulations below as the software uses a formula that includes a log-likelihood estimate 
contingent on the provided sample size. 
 
QSNP Test of Heterogeneity 
As with the computation of model 2 outlined above, QSNP is calculated using a two-step 
procedure. In Step 1, a common pathway model is fit in which both factor loadings, the SNP effect on the 
common factor(s), and the residual variances of the common and unique factors are freely estimated (with 
one factor loading fixed to unity for factor identification and scaling). No paths representing direct effects 
of the SNP on the genetic components of the individual phenotypes are estimated. In Step 2, a common 
plus independent pathways model is specified, in which the factor loadings and the SNP effect on the 
common factor are fixed to the values estimated in Step 1, and direct effects of the SNP on individual 
indicators and the residual variances of each indicator are freely estimated. Supplementary Fig. 33 depicts 
this model, as applied to a single common factor model, with parameters that are fixed in Step 2 depicted 
in red and those that are freely estimated in Step 2 depicted in black. 
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Null Distribution of QSNP. To verify that the null distribution for QSNP is 2 distributed, a set of simulations 
specified a generating population in which the direct effects of the SNP on the indicators were entirely 
mediated through the common factor. Each simulation included 1,000 datasets, with N = 100,000 
completely overlapping participants per dataset. All simulated datasets were analyzed using both WLS 
and ML. We examined three models with F = 1 factor, and k = 4, 5, or 6 phenotypes. Table S21 presents 
descriptive statistics for QSNP. Using a genome-wide significance threshold, in all cases the false 
discovery rate for QSNP was 0, and the power to detect a SNP effect on the common factor was 1. Both 
WLS and ML estimation produced mean estimates of QSNP that were approximately equal to the df of the 
corresponding model. Supplementary Fig. 34 depicts the null sampling distributions of QSNP estimated 
using WLS or ML. Supplementary Fig. 35 plots QSNP from these two estimation methods against 2 
distributions and against one another. These results indicate that both estimation methods produce results 
that are approximately 2 distributed. 
 
Genomic SEM Simulation Procedures 
Simulation of Factor Structure. In order to evaluate the ability of Genomic SEM to capture the genetic 
factor structure in the generating population, the GCTA package3 was used to generate 100 sets of 6 
independent, 100% heritable phenotypes (“orthogonal genotypes”) to pair with genotypic data for 39,909 
randomly selected, unrelated individuals of European descent from UKB data for the 1,209,498 SNPs 
present in HapMap3. The generating list of causal SNPs was set to 10,000 for all 600 genotypes, with the 
specific list of causal variants sampled with replacement from the 1,209,498 SNPs. One of the six 
orthogonal genotypes per set was designated an index of the general genetic factor and the remaining five 
were designated indices of domain-specific genetic factors. All of these orthogonal genotypes were scaled 
to M=0, SD=1. Five new correlated genotypes were then constructed, each as the weighted linear 
combination of the general genetic factor and one domain-specific genetic factor. Weights for 
contribution of the general genetic factor were λFg,k =.70, .60, .50, .40, and .30, for correlated genotypes 1- 
5, respectively. Weights for the domain-specific factors were 2(1 −  λ( ). Phenotypes were then each 
 
constructed as the weighted linear combination of one of the correlated genotypes and domain-specific 
environmental factors (randomly sampled from a normal distribution with M=0, SD=1). Heritabilities for 
phenotypes 1-5 were set to ℎ(=35%, 40%, 50%, 60%, and 70%, respectively, such that the weights for 
the genotypes were 2ℎ( and the weights for the environmental factors were 2(1 − ℎ(). We chose these 
. . 
 
figures to stabilize the properties of the distributions across simulations at 100 replications with N~39K 
each. We expect that with lower SNP h2’s, the same patterns would hold, albeit at larger sample sizes. 
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Each of the 500 phenotypes (100 sets of 5 phenotypes) was then analyzed as a univariate GWAS in 
PLINK56 to produce univariate GWAS summary statistics. Our multivariable LDSC function was then 
used to construct 100 sets of 5×5 genetic covariance matrices (S) and associated sampling covariance 
matrices (VS), and Genomic SEM was used to fit a one factor model to each set. 
 
Simulation of Partial Sample Overlap. In order to examine the effect of sample overlap on estimates 
obtained from Genomic SEM, the GCTA package package3 was used to generate a 50% heritable, 
quantitative phenotype with 30,000 causal SNPs. The phenotype was paired with genetic data from 
100,000 randomly selected, unrelated individuals of European descent from UKB data for 1,209,498 
HapMap3 SNPs. Three sets of 60,000 participants each were created using this same phenotype, with 
40,000 participants overlapping across all three identical phenotypes and 20,000 participants unique to 
each phenotype (i.e., 100,000 total participants). These three subsamples were individually analyzed in 
PLINK56 to produce univariate GWAS summary statistics. The multivariable LDSC function was then 
used to construct the genetic covariance and sampling covariance matrix using the three sets of summary 
statistics, and Genomic SEM was used to fit a one factor model with the SNP predicting the common 
factor. Two key pieces were verified at this stage. First, we confirmed that the standardized factor 
loadings on the common factor were 1 for the identical phenotypes. Second, we verified that the bivariate 
ld-score intercepts that are used to account for sample overlap in the sampling covariance matrix were as 
expected. The equation for the ld-score bivariate intercept is4: Ns/√(N1N2), where Ns = sample overlap, 
= the phenotypic correlation, N1 = sample size of trait 1, and N2 = sample size of trait 2. In this simulation, 
we observed bivariate intercepts of .67, which is as expected given sample overlap of 40,000, a 
phenotypic correlation of 1, and sample sizes of 60,000 (i.e., 40,000*1/√(60,000*60,000) = .67). Finally, 
estimates from this multivariate GWAS were compared to estimates from the univariate GWAS in 
PLINK for the full set of 100,000 participants. 
 
MTAG Simulation. In order to evaluate the relationship between estimates from MTAG and those from a 
Genomic SEM formulation of the MTAG model, we specified a bivariate system of heritable 
phenotypes, A and u. Phenotype A was constructed using the GCTA package3, and specified to be 60% 
heritable, and affected by a random selection 30,000 HapMap3 SNPs. Phenotype u was constructed 
separately using the GCTA package, and also specified to be 60% heritable, and affected by a different 
random selection of 30,000 HapMap3 SNPs. Both A and u were standardized (M=0, SD=1). Phenotype B 
was constructed from phenotypes A and u according to the equation B = .7A + .7u. This procedure 
resulted in 60% heritabilities for both traits A and B, with a genetic correlation of .7 between them. 
Sample sizes for phenotypes A and B were 25,000 each, with 10,000 participants contributing data for 
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both phenotypes A and B (i.e. 40% sample overlap), such that the analytic dataset was composed of 
40,000 unique individuals in total. Both MTAG11 and a Genomic SEM model specified to satisfy the 
same moment conditions as MTAG (see Online Supplement) were then each run with Trait A as the 
supporting phenotype used to boost power for target Trait B and estimates from MTAG and Genomic 
SEM specified as MTAG were compared. 
 
Quality Control Procedures 
LD-Score Regression. For the p-factor, neuroticism, and anthropometric traits, quality control (QC) 
procedures for producing the S and VS matrix followed the defaults in LDSC. We recommend using these 
defaults for multivariable LDSC, including removing SNPs with an MAF < 1%, information scores < .9, 
SNPs from the MHC region, and filtering SNPs to HapMap3. Quality control procedures for the 
multivariable regression example mirrored those used by Nieuwboer et al. (2016)25 for comparative 
purposes. More specifically, SNPs were excluded with MAFs < .05 as determined by the HapMap 
Consortium,57 and with information values less than 0.9 or greater than 1.1. SNPs were also filtered to 
HapMap3. The LD scores used for the analyses presented were estimated from 1000 Genomes Phase 3, 
but restricted to HapMap3 SNPs. 
 
Multivariate GWAS. Summary statistics are only restricted to HapMap3 SNPs for the estimation of the 
genetic covariance and sampling covariance matrix in LD-Score regression, whereas all SNPs passing QC 
filters are included for multivariate GWAS. To obtain summary statistics for multivariate GWAS, we 
recommend using QC procedures of removing SNPs with an MAF < .01 in the reference panel, and those 
SNPs with an INFO score < 0.6. MAFs were obtained for the current analyses using the 1000 Genomes 
Phase 3 reference panel. Using these QC steps, 1,979,881 SNPs were present across schizophrenia, 
bipolar disorder, MDD, PTSD, and anxiety. For neuroticism, there were 7,265,104 SNPs that were 
present across all phenotypes. These QC procedures are the defaults for the processing function within the 
GenomicSEM package. The regression effects for the univariate indicators of the p-factor were 
standardized using the procedure for logistic coefficients outlined above. Regression effects for 
neuroticism indicators were converted from linear probability to logistic coefficients and then 
standardized with respect to the variance in the outcome. 
 
Out-of-Sample Prediction 
p-factor. Genomic SEM analyses that were used to produce the summary statistics for construction of 
polygenic scores for out-of-sample prediction omit the PGHC MDD 2018 GWAS and SCZ 2018 GWAS 
and replace them with the PGC MDD 201358 and PGC SCZ 201459 GWAS to prevent overlap between 
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discovery and target samples. This resulted in a Genomic SEM-based multivariate GWAS using 930,581 
SNPs. Analyses used to construct a phenotypic p-factor for polygenic prediction in the UKB dataset were 
restricted to data on up to N=332,050 European participants. The Genomic SEM of the p-factor employed 
case-control GWAS statistics to construct summary statistics for a general factor of liability for clinically- 
severe levels of psychopathology as the discovery phenotype. For out-of-sample prediction, we selected a 
set of psychiatric symptoms (rather than diagnoses) to construct liability for general and domain-specific 
factors of psychiatric symptomology across the subclinical-to-clinical ranges as the target phenotypes. 
From the UKB dataset, we chose symptoms falling within the following domains: psychosis, mania, 
depression, post-traumatic stress, and anxiety. We fit a confirmatory factor model (diagram shown in 
Supplementary Fig. 29) to the phenotypic symptom endorsements, treating them as ordered categorical 
variables. Analyses were run in Mplus,60 with the target phenotypes—the p-factor and each of the 
individual domains—specified as latent variables. PGS variables were specified to directly predict the 
latent phenotypes within the model (i.e., factor score estimates were not used). To construct PGSs, we 
removed from both the p-factor and univariate summary statistics the 5 SNPs that were identified as 
having genome-wide significant QSNP estimates for ML, along with SNPs that were in LD with these 
SNPs using an r2 threshold of 0.1 and 500-kb window. PGSs were constructed using PRSice,61 with LD 
clumping set to r2 > 0.25 over 250kb sliding windows. PGSs for the p-factor were based on the WLS 
summary statistics produced using Genomic SEM. We ran PGS analyses using a p-value threshold of 1.0 
(i.e., we used all available SNPs apart from those removed due to QSNP analyses). In order to maintain 
comparability, PGSs for the univariate summary statistics were constructed based on the same SNPs with 
which the PGSs for the p-factor were constructed. In the confirmatory factor models, we included 
controls for age, sex, genotyping array, and 40 principal components of ancestry in conjunction with the 
PGS predictor. 
 
Neuroticism. The raw total on the 12-item neuroticism subtest of the Eysenck Personality Questionnaire- 
Revised62 (maximum score = 12) was used as the target phenotype for out-of-sample prediction. Both 
genetic and neuroticism target data was available on 19,876 European participants in the Generation 
Scotland cohort63. Neuroticism scores were residualized for age, sex, and 20 principal components of 
ancestry prior to examining out-of-sample prediction. PGSs were constructed using PRSice,61 with LD 
clumping set to r2 > 0.25 over 250kb sliding windows and using a p-value threshold of 1.0. PGSs for 
neuroticism were based on the WLS summary statistics produced using Genomic SEM. Regression 
analyses were run using the lmekin function within the coxme package in R with a random intercept to 
account for nesting of individuals within families. 
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Clumping and Biological Annotation 
Lead SNPs for univariate indicators and the common factors were identified using the clumping 
algorithm in PLINK.56 We defined LD-independent SNPs using an r2 threshold of 0.1 and a 500-kb 
window using the same 1000 Genomes Phase 3 reference panel used for obtaining MAF. For 
chromosomes 6 and 8 an additional pruning filter was used of 1Mb and r2 > 0.1 to account for long-range 
LD due to the MHC region and pericentric inversion, respectively. Increasing the pruning window further 
to 4Mb did not influence our findings on chromosome 6 or 8. The lead SNPs identified using PLINK 
were entered into DEPICT. Prioritized genes, enriched gene sets, and enriched tissues were identified 
using the standard false discovery rate of 5%. 
 
Description of GenomicSEM Software 
The Genomic SEM software package, GenomicSEM, is written as an R package and is available 
through GitHub at https://github.com/MichelNivard/GenomicSEM. GenomicSEM contains several 
functions, including procedures for QCing and standardizing summary statistics, a function for producing 
genetic covariance matrices (SLDSC) and their associated sampling covariance matrices (VSLDSC) using a 
multivariable extension of LD Score regression, functions for fitting Genomic Structural Equation Models 
to SLDSC  and VSLDSC, and functions for adding SNP level data to the SLDSC  and VSLDSC  matrices (referred to as 
SFull  and VSFull) that are used for implementing Genomic SEM for multivariate GWAS discovery. Functions 
include both pre-specified models (e.g., a single common factor model) and user-specified models. Output 
includes both unstandardized and standardized solutions, along with the fit indices described above. WLS 
estimation is the default in the GenomicSEM package. GenomicSEM uses the lavaan Structural Equation 
Modeling package64 as the primary workhorse for model specification and numerical optimization. We also 
provide limited support for OpenMx.65 To run the multivariable LDSC function on five phenotypes takes 
~15 minutes, a step in the analyses that only needs to be performed once. For models of multivariate genetic 
architecture that do not incorporate individual SNP effects, the typical run time observed for 3-15 traits is 
<1 second on a standard personal computer. Using parallel processing implemented in the GenomicSEM 
package on a 4-core/8-thread laptop, a multivariate Genomic SEM GWAS with five indicators and ~1 
million SNPs took ~8 hours. With the time needed to run the models will increase with increasing model 
complexity, and with increasing numbers of variables or SNPs. In these cases, computing time can be 
greatly reduced by using a computing cluster to distribute SNP models across nodes/cores. 
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 Software 
GenomicSEM software is an R package that is available from GitHub at the following URL: 
https://github.com/MichelNivard/GenomicSEM 
The GenomicSEM R package can be installed directly at: 
https://github.com/MichelNivard/GenomicSEM/wiki. 
Example GenomicSEM code, including code used to produce results is provided for each set of analyses 
at the following online wiki: https://github.com/MichelNivard/GenomicSEM/wiki. 
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Table 1. Summary of multivariate (Genomic SEM) and univariate GWAS results. 
 
Lead SNPs Unique No. of 
No. No. 
Mean 
 
 
 
SEM (WLS) 
 
 
 
 
 
 
SEM (WLS) 
 
 
 
 
 
 
 
 
 
 
 
 
Note. In parentheses for QSNP reports how many QSNP hits were in LD with hits identified as significant for 
the common factor. Unique hits for the common factor refers to lead SNPs that were not in LD with hits for 
the individual indicators. Unique hits for the individual indicators refers to hits for the respective indicator 
that were not in LD with hits for the common factor. Unique hits for the common factor excluded hits in LD 
with QSNP hits. For unique hits for indicators, values in parentheses indicate whether any of these hits were 
identified as significant for QSNP. For unique hits for the common factor, hits were excluded that were in LD 
with previously reported indicator hits that were removed due to missing values across the other phenotypes. 
The single QSNP hit for WLS estimation of the p-factor was significant for both the common factor and 
schizophrenia. For the common factor and the indicators, independent hits were defined using a pruning 
window of 500Kb and r2 > 0.1. For chromosomes 6 and 8, an additional pruning filter was used of 1Mb and 
r2 > 0.1 to account for long-range LD due to the MHC region and pericentric inversion, respectively. For 
univariate statistics, we used only the SNPs present across all indicators in order to facilitate a direct 
comparison to Genomic SEM results. 
(p < 5 × 10-8) 
QSNP hits 
Hits gene sets 
prioritized
 tissues 
2
 
    genes and cells  
  P-Factor     
Genomic 
128
 
1 (1) 27 71 37 24 1.88 
chizophrenia 127 - 34 (0) 2 25 21 1.82 
Bipolar 4 - 4 (0) 0 0 0 1.15 
MDD 5 - 5 (0) 0 0 0 1.31 
PTSD 0 - 0 (0) 0 0 0 1.01 
Anxiety 1 - 1 (0) 0 0 0 1.03 
  Neuroticism     
Genomic 
118
 
69 (5) 38 1 19 20 1.64 
Mood 43 - 19 (5) 0 0 15 1.37 
Misery 31 - 6 (4) 0 0 0 1.32 
Irritability 36 - 17 (4) 0 0 0 1.37 
Hurt Feelings 24 - 11 (0) 0 0 0 1.33 
Fed-up 38 - 21 (6) 0 0 0 1.36 
Nervous 41 - 25 (12) 0 0 0 1.36 
Worry 56 - 26 (6) 0 13 0 1.46 
Tense 19 - 10 (3) 0 0 0 1.32 
Embarrass 17 - 6 (2) 0 0 0 1.33 
Nerves 12 - 7 (3) 0 0 0 1.26 
Lonely 6 - 4 (3) 0 0 0 1.19 
Guilt 21 - 8 (1) 0 0 0 1.28 
 
Genomic SEM 39 
 
 
 
a 
 
 
 
 
 
 
 
 
 
 
 
 
 
.26 (.11) .35 (.11) .79 (.07) .91 (.44) .71 (.36) 
b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
.25 (.01) 
 
.28 (.02) .43 (.02) .35 (.03) .33 (.02) 
 
.46 (.03) .39 (.02) .36 (.03) 
 
.52 (.03) 
 
.37 (.03) 
 
.50 (.04) 
 
.37 (.03) 
Fig. 1. Genomic SEM solutions for p-factor and neuroticism factor models with SNP effect. 
Standardized results from using Genomic SEM (with WLS estimation) to construct a genetically defined 
p-factor of psychopathology (panel a) and a genetic neuroticism factor (panel b) with a lead independent 
SNP predicting the factors. SEs are shown in parentheses. For a model that was standardized with respect 
to the outcomes only, the effect of the SNP was -.093 (SE = .017; SNP variance = .252) for the p-factor, 
and for neuroticism the SNP effect was -.042 (SE = .007, SNP variance = .432); this can be interpreted as 
the expected standard deviation unit difference in the latent factor per effect allele. SCZ = schizophrenia; 
BIP = bipolar disorder; DEP = major depressive disorder; PTSD = post-traumatic stress disorder; ANX = 
anxiety. Irr = irritability; Feel = sensitivity/hurt feelings; fed-up = fed-up feelings; emb = worry too long 
after embarrassment. 
1 uN .999 (.058) 
-.028 (.005) 
1 Ng 
  .87 (.02)    .75 (.04)    .81 (.02)   .80 (.03)   .79 (.03)   .80 (.03)  
Moodg Miseryg Irrg FeelG Fed-upG Nervousg Worryg Tenseg Embg Nervesg 
Lonelyg Guiltg 
1 1 1 1 1 1 1 1 1 
1 1 
uMood uMis uIrr uFeel uFed-up uNervous uWorry uTense uEmb uNerves uLonely uGuilt 
.78 (.03) .73 (.03) .71 (.03) .69 (.03) .81 (.03) .85 (.03) 
 
rs10497655 
1 up .998 (.049) 
-.045 (.008) 
1 rs4552973 p G 
.86 (.06) .53 (.08) 
.81 (.06) .29 (.09) 
.46 (.04) 
SCZg BIPg DEPg PTSDg ANXg 
1 1 1 1 1 
uSCZ uBIP uDEP uPT uANX 
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Fig 2. Manhattan plots of unique, independent hits from Genomic SEM. Genomic SEM (with WLS estimation) was used to conduct multivariate GWASs 
of the p-factor (panel a) and neuroticism (panel b). Manhattan plots are shown for SNP effects (left panels) and for QSNP (right panels). The gray dashed line 
marks the threshold for genome-wide significance (p < 5 × 10-8). In all four panels, black triangles denote independent hits for SNP effects from the GWAS of 
the general factor that were not in LD with independent hits for the univariate GWAS or hits for QSNP. In all four panels, purple diamonds denote independent 
hits for the SNP effects from univariate GWASs that were not in LD with independent hits from the GWAS of the general factor. Grey stars denote 
independent hits for QSNP. 
Genomic SEM 41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Out-of-sample prediction using Genomic SEM based and univariate based polygenic scores for psychiatric traits. Polygenic scores 
(PGSs) were constructed using the same set of SNPs for all predictors. R2 (%) on the y-axis indicates the percentage of variance (possible range: 0- 
100) explained in the outcome unique of covariates. The summary statistics for Genomic SEM were estimated using WLS. The Genomic SEM 
based PGS was derived from a model estimating SNP effects on a common “p”-factor, constructed from SCZ, BIP, MDD, PTSD, and ANX (as in 
Fig. 1a.). In order to prevent bias, the Genomic SEM summary statistics were produced using SCZ and MDD GWAS summary statistics that did 
not include UKB participants. Error bars indicate 95% confidence intervals estimated using the delta method. Phenotypes were constructed for 
European participants in the UKB for five symptom domains and for a general p factor spanning all five symptom domains. 
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Fig. 4. Relative power and out-of-sample prediction for neuroticism. Panel a represents relative power of 
GWAS summary statistics for individual neuroticism items (yellow), parcels (blue), and factor of parcels, 
sum score, and factor of items (purple) from in the UKB discovery sample. Relative power is indexed by the 
proportion (expressed as a percentage) in the average 2 – 1 across summary statistics relative to the lonely 
item (panel), which is the item with the smallest average 2 value. We subtract 1 because the mean of the null 
2 distribution is equal to its degrees of freedom. Panel b represents relative prediction in the Generation 
Scotland sample for polygenic scores (PGSs) derived from GWAS sumstats for individual neuroticism items 
(yellow), parcels (blue), and factor of parcels, sum score, and factor of items (purple). The proportional R2 
(%) is relative to the R2 for the lonely item PGS. PGSs were constructed using the same set of SNPs for all 
predictors. The summary statistics for Genomic SEM were estimated using WLS. Error bars indicate 95% 
confidence intervals. For both panels, the red line is drawn at 100%, to indicate distance from the lonely item 
baseline. The superior performance of Genomic SEM analysis of the common factor of items relative to the 
sum score of the items is likely, in part, a reflection of the fact that the sum score in UKB was created using 
listwise deletion, resulting in a reduced sample size of 274,008. Conversely, Genomic SEM uses all available 
information from neuroticism items, with sample sizes of ~325,000 each. In more severe cases of sample non- 
overlap, we would expect even larger power benefits of Genomic SEM-derived summary statistics relative to 
individual items or sum scores. Indeed, in instances of minimal sample overlap, it is not possible to compute 
sum scores, but Genomic SEM can still be used to integrate GWAS summary data across phenotypes. 
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Fig. 5. Biological annotation of Genomic SEM results for p-factor, neuroticism, and QSNP of 
neuroticism. Results from tissue enrichment analyses conducted using DEPICT based on Genomic SEM 
results for the p-factor (panel a), neuroticism (panel b) and QSNP estimation for neuroticism (panel c) using 
WLS estimation. The red, dashed line indicates the false discovery rate at .05. As expected, the majority of 
enriched tissues were in the nervous system for both common factors and QSNP estimates. 
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ML Estimation 
 
WLS estimation more heavily prioritizes reducing misfit in those cells in the S matrix that are 
estimated with greater precision. This has the desirable property of potentially reducing standard errors of 
the Genomic SEM parameter estimates, which may boost power for SNP discovery and increase 
polygenic prediction. However, because the cells in the VS matrix (that index the precision of cells in the S 
matrix) are contingent upon the sample sizes for the contributing univariate GWASs, WLS may produce a 
solution that is dominated by the patterns of association involving the better powered GWASs, and 
contain substantial local misfit in cells of S that are informed by lower powered GWASs. In other words, 
WLS relative to ML may more heavily prioritize minimizing sampling variance of the parameter 
estimates in the so-called variance bias tradeoff.37 We expect that this will only occur when the model is 
overidentified (i.e., df > 0), such that exact fit cannot be obtained, and that divergence in WLS and ML 
estimates will be most pronounced when there is lower sample overlap and the contributing univariate 
GWASs differ substantially in power. 
In the case of our Genomic SEM formulation of GWIS, the model was just identified (df = 0) and 
results from ML were highly consistent with those from WLS (Supplementary Fig. 23). For 
anthropometric traits, results were also highly similar across ML and WLS, with ML estimation also 
confirming two latent factors with a modest genetic correlation (rg = .21, SE = .05, p < .001). In the case 
of psychiatric traits, we use summary statistics characterized by discrepant sample sizes and low levels of 
sample overlap for which the expectation is potentially divergent WLS and ML estimates. Indeed, WLS 
and ML findings were discrepant, with MDD loading strongest on the p-factor with ML estimation 
(Supplementary Fig. 24), but SCZ loading strongest on the p-factor with WLS estimation. The follow-up 
models used to calculate model fit failed to converge for ML estimation of both the p-factor and 
anthropometric traits. For neuroticism, results were highly consistent across WLS and ML estimation—as 
would be expected giving almost entirely overlapping univariate samples—revealing a common 
neuroticism factor with strong loadings for all indicators and good model fit (2[54] = 4959.08, AIC = 
5007.08, CFI = .891, SRMR = .116; Supplementary Fig. 24). 
For SNP effect models estimated using ML, there was minimal enrichment of effects for the p- 
factor, but effects were similar to WLS for neuroticism (Supplementary Fig. 25 for QQ plot). More 
specifically, there were no lead SNPs identified for the p-factor with ML estimation and 105 lead SNPs 
identified for neuroticism with ML estimation. For estimates of QSNP, there were 63 independent hits for 
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the p-factor and 63 independent hits for neuroticism. Inspection of QSNP estimates for the p-factor 
indicated that these results were largely driven by SNPs that were highly significant for schizophrenia, but 
not the other indicators (Table S19). As expected based on higher sample overlap and less discrepant 
sample sizes for neuroticism compared to the p-factor, the association between p-values for ML and WLS 
were higher for neuroticism (r = .94) than for the p-factor (r = .15; Supplementary Fig. 26). However, the 
association between QSNP estimates was high for both the p-factor (r = .77) and neuroticism (r = .99; 
Supplementary Fig. 26). Biological annotation of ML-based results conducted using DEPICT revealed all 
null findings for the p-factor, and 6 prioritized genes, no gene sets, and 23 tissues for neuroticism. Loci 
identified for ML estimation of neuroticism and QSNP estimates for the p-factor and neuroticism were 
expressed in the nervous system (Supplementary Fig. S27). 
 
Model Comparisons: Neuroticism Example 
As an example of how to use Genomic SEM to do model comparisons we examined different 
factor structures that might be fit to the 12 neuroticism items from UK Biobank. As a starting point, we 
performed an Exploratory Factor Analysis (EFA) in the fa R package using the oblimin rotation for a two- 
, three-, and four-factor solution. A follow-up CFA (Supplementary Fig. 5) within Genomic SEM was 
specified based on the EFA parameter estimates (standardized loadings > .4 were retained) for the two- 
and three-factor solutions, but not the four-factor solution as the fourth factor was defined only by the 
tense and irritability items (Table S2). The two-factor solution (2[53] = 2758.18, AIC = 2808.18, CFI = 
.940, SRMR = .077) and three-factor solution (2[51] = 1879.31, AIC = 1933.31, CFI = .959, SRMR = 
.057) both provided excellent fit to the data. For both solutions, the factors were highly correlated (rg  
.67). As these were not nested models, they could not be compared using 2 difference tests. 
There were 69 SNPs identified as significantly heterogenous for the common factor of 
neuroticism, indicating that these particular SNPs may be operating through factors defined by a smaller 
subset of items. In order to investigate this possibility, multivariate GWAS analyses were conducted for 
these 69 QSNP hits using the two- and three-factor solutions identified above. The SNP was specified to 
predict all factors in each model. Of these 69 SNPs, 28 and 20 were genome-wide significant for QSNP for 
the two- and three-factor solutions, respectively (Table S3). For the two-factor solution, 6 SNPs had a 
genome-wide significant effect on the first factor and 4 SNPs were significant for the second factor. For 
the three-factor solution, 5 SNPs were significant for the first factor, 1 was significant for the second 
factor, and 9 were significant for the third factor. Taken together, these results indicate that a proportion 
of the SNPs identified as significantly heterogenous for the single factor solution may have large effects 
on individual factors defined by a smaller subset of the neuroticism items. Indeed, plots of item-level 
effects for SNPs identified as significant for one of the factors indicate high levels of consistency within, 
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but not across, factors (Supplementary Fig. 6). For SNPs that continued to be significant for QSNP for even 
the three-factor solution, the effect may be even finer grained, with outlying effects on individual items. 
The iterative process outlined here of beginning with a common factor, and following up on SNPs 
identified as having high degrees of heterogeneity in more nuanced models, can be used to bin SNPs into 
categories of decreasing pleiotropic effects within a set of genetically correlated traits (Supplementary 
Fig. 6). 
 
MTAG as a Model within Genomic SEM 
Here we examine the connection between the MTAG model and Genomic SEM. 
MTAG Moment Conditions. MTAG builds onto the LDSC framework, where K phenotypes and M SNPs 
are measured in N individuals, and modeled according to the equation: 
i,k    xi , j  j ,k   Úi,k , (1.1) 
 
where i ,k is the score for person i on phenotype k, x is the standardized genotype for person i on SNP j, 
βj,k the true genotype effect size for SNPj on phenotype k, and ϵi,k is the residual for person i on phenotype 
k. Written in matrix form, we have: 
 
Φ = XB + E , (1.2) 
 
where Φ is an N× K matrix of scores for person i on phenotype k, X is an N×M matrix of standardized 
genotypes for person i on SNP j, B is an M×K matrix of true genotype effect sizes for SNP j on 
phenotype k, and Ei,k is an N×K matrix of residuals for person i on phenotype k. 
In this framework, LDSC is used to model βj,k as phenotype-specific random effects, varying over 
SNPs, with E(βj,k)= 0 and cov(βj,k)= Ω. The diagonal elements of Ω contain the average heritability 
explained per SNP ( h
2 
/ M ; alternately referred to as genetic variance explained per SNP, i.e.,  2 / M ), 
k k 
and the off diagonal elements of Ω contain the genetic covariances between phenotypes on a per-SNP 
scale (/M, where  is the genetic covariance between pairs of phenotypes). In other words Ω is 
equivalent to 
! 
𝑆LDSC, where SLDSC is the genetic covariance matrix estimated with LDSC that is used in 
" 
Genomic SEM. 
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
j ,k 
t 
t 
2 
 
 
By drawing on multivariate GWAS summary statistics from K genetically correlated phenotypes, 
 
j ,t 
MTAG attempts to obtain an estimate of the effect size for SNP j on target phenotype t that is more 
ˆ 
precise than the univariate GWAS estimate, j,t , of this effect. In the notation of Turley et al. (2018)11, 
 
the MTAG moment condition specifies: 
 
E
 
ˆ 






j,k   
 
 
kt 
tt 
 
 

j,t 





(1.3) 
where ˆ is the GWAS estimate for the regression effect of SNP j on phenotype k,  is the (k,t)th 
kt 
element of Ω (i.e., elements drawn from the tth column of Ω), and tt is the (t,t)th element of Ω. In other 
words,  
kt 
is the LDSC-estimate of per-SNP scaled genetic covariances between each phenotype and the 
target phenotype and 
tt 
is the LDSC estimate of the per-SNP genetic variance (i.e. per-SNP heritability) 
of the target phenotype. 
 
We can rewrite the MTAG moment condition in notation that is more germane to Genomic SEM. 
We write the GWAS estimate for the regression effect of SNP j on phenotype k as βGWAS j,k. We write the 
LDSC estimate of per-SNP scaled genetic covariance between phenotype k and target phenotype t as 
σk,t/M, and we write the LDSC estimate of per-SNP genetic variance in target phenotype t as  
2 
/ M . 
Finally, we write the effect size for SNP j on target phenotype t that MTAG attempts to estimate as βMTAG 
j,k. Under this notation, the MTAG moment condition takes the form: 

GWAS j ,k 
 
 k ,t / M 

 2 / M 
 
 
 
MTAG j ,t 
 0 
. (1.4) 
Cancelling M from the numerator and denominator of the quotient and rearranging yields: 

GWAS j ,k 
 
k ,t 
t 
 
 
 
 
MTAG j ,t 
 
 
. (1.5) 
Standard covariance algebra holds that the covariance between variables x and y divided by the variance 
of x is equivalent to the unstandardized regression effect of x on y. We therefore obtain that the LDSC- 
derived genetic covariance between k and t divided by the LDSC-derived genetic variance of t is 
equivalent to an LDSC-inferred structural regression effect of the genetic component of phenotype t on 
the genetic component of phenotype k, which we label 
to: 
 
 
LDSC t ,k 
. The moment condition therefore reduces 
 0 
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Solving for 









MTAG j ,t 
 
 
 
, we obtain: 

GWAS j ,k 
  
LDSC  t ,k       MTAG  j ,t  . (1.6) 
 
 


MTAG j ,t  
GWAS  j ,k 

LDSC t ,k 
 
. (1.7) 
 
 
Genomic SEM Covariance Expectations. We can specify a model within Genomic SEM that satisfies 
these same moment conditions as MTAG. We write a model in which the genetic component Yk of each 
phenotype k, is regressed on the genetic component Yt of t, and Yt is regressed on SNP j: 
Yk  = βLDSC t,k × Yt  + ek , (2.1) 
 
Yt = βMTAG j,t × SNPj  + ut , (2.2) 
 
or in path diagram form (for two phenotypes, t and k) as: 
 
 
 
 
This model produces the following expectations with respect to the GWAS-estimated covariance 
between SNP j and phenotype k: 
 

GWAS j ,k 
2 
SNPj 
 
MTAG j ,t LDSC t ,k , (2.3) 
 
which rearranging yields:  

GWAS j ,k 
 
 
  
2 
SNPj 
MTAG j ,t LDSC t ,k 
. (2.4) 
 

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As the covariance between SNPj and phenotype k divided by the variance of SNPj is equal to the 
regression effect of SNPj on phenotype k, we have: 
 
 
Solving for 








MTAG j ,t 
 
 
 
, we obtain: 

GWAS j ,k 
  
MTAG  j ,t        LDSC t ,k  . (2.5) 
 
 


MTAG j ,t  
GWAS  j ,k 

LDSC t ,k 
 
, (2.6) 
which is the same equality obtained when solving for 
equation 1.7 above. 
 
 
 
MTAG j ,t 
from the MTAG moment condition, in 
 
 
Optimization. Both the MTAG moment condition and the specific Genomic SEM model specified to 
satisfy the MTAG moment condition yields: 

MTAG j ,t 

 GWAS  j ,k 
LDSC t ,k 
 
 
. (3.1) 
As there are K phenotypes, including the target phenotype, this yields a system of equations that 
is overidentified, in the sense that there are more knowns than free parameters. In, for example, the two- 
phenotype circumstance (1 target phenotype, t, and one supporting phenotype, s), the free parameter 

MTAG j ,t 
is equivalent to two separate terms: 
 

MTAG j ,t 
 

 GWAS  j ,s 
LDSC t ,s 
 
 
 
 
, (3.2) 
and 
 

MTAG j ,t  
GWAS j ,t 
LDSC t ,t 
GWAS j ,t 
1 
 
GWAS j ,t  
. (3.3) 
In both MTAG and Genomic SEM, free parameters are estimated by minimizing a fit function. 
The MTAG fit function minimizes the weighted squared discrepancies between the MTAG-implied 
GWAS estimates and the univariate GWAS estimates for all K phenotypes. In the notation of Turley et al. 
(2018),11 this is written as: 
  
' 
  
 ˆ j   

t
 
 j ,t   W  ˆ j   
t
  j ,t 
 tt   tt  , (3.4) 
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j 

 
j 
 
where W is a weight matrix, ˆ is the vector of betas for the effect of SNPj on phenotype k estimated from 
 
 
univariate GWAS, and 

t  


tt 
 
 
 
j ,t 
 
is the vector of SNP-phenotype betas that is implied by MTAG (by 
multiplying the MTAG estimate for the GWAS effect on target trait t by the LDSC-inferred structural 
regression effect of the genetic component of phenotype t on the genetic component of phenotype k). 
 
This takes the same form as the WLS fit function in Genomic SEM, which minimizes the 
weighted squared discrepancies between all elements in the full genetic covariance matrix (combined 
both from elements derived from LDSC and elements derived directly from GWAS estimates) and those 
implied by the specified model, according to: 
s    W s   , (3.5) 
where W is a weight matrix, s is the half-vectorized empirical genetic covariance matrix (S), and    is 
the half-vectorized model-implied genetic covariance matrix (Σ(θ)). 
 
The weight matrices, W, in MTAG and Genomic SEM are very similar. In Genomic SEM, W is 
the inverse of the diagonal matrix DS that contains the diagonal elements of VS on its diagonal, where VS is 
the sampling covariance matrix of all of the elements in S, and SEs of parameter estimates θ are obtained 
via sandwich estimation using the full VS matrix. In MTAG, W is the inverse of a similar sampling 
covariance matrix of the MTAG-implied GWAS estimates. In the notation of Turley et al. (2018),11 this 
matrix is formed as: 
 
  '  
1 
  t     t   
 tt   , (3.6) 
 
where  is the LDSC-derived genetic covariance matrix among the phenotypes on a per-SNP scale, 
t 
is 
the vector of estimates from column t of  that contains the genetic covariances between each phenotype 
and the target phenotype, 
tt 
is the per-SNP genetic variance (per-SNP heritability) of the target 
phenotype, and Σj is the sampling covariance of the univariate GWAS effects, which is equivalent (after 
transformation) to the elements of the portion of the Vs matrix from Genomic SEM that contains sampling 
' 
     t t  
covariances of the GWAS effects (VSNP) obtained from the cross-trait LDSC intercepts. The term 
reduces to a matrix of genetic variances and covariances among the phenotypes mediated by their 
tt 
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 
 
 
 
structural regressions on the genetic component of phenotype t, such that 
 
' 
 t t  
tt 
 
 
represents per-SNP 
scaled residual genetic covariances among the phenotypes after controlling for genetic variance in target 
phenotype t. The addition of these residual genetic covariances to the sampling covariance of the 
univariate GWAS effects in constructing the MTAG W matrix results in the fit function downweighting 
the contribution of GWAS estimates for supporting phenotypes that have lower genetic correlations with 
the target phenotype. 
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a Unstandardized 
 
 
 
 
 
 
 
 
 
 
 
 
 
.18 
(.17, 1.08) 
(.17, 1.09) 
 
 
b 
.26 
(.24, 1.02) 
(.24, 0.99) 
 
.38 
(.33, 1.05) 
(.32, 1.08) 
Standardized 
 
.50 
(.46, 1.16) 
(.45, 1.15) 
 
.63 
(.57, 1.09) 
(.57, 1.09) 
 
 
 
 
 
 
 
 
 
 
 
 
.51 
(.53, 1.22) 
(.53,  1.24) 
 
.64 
(.66, 1.25) 
(.66, 1.24) 
.75 
(.74, 1.26) 
(.73, 1.27) 
.84 
(.85, 1.56) 
(.84, 1.58) 
.91 
(.91, 1.79) 
(.91, 1.81) 
 
Fig. S1. Genomic SEM simulation results. Results from 100 runs of Genomic SEM using data 
simulated at the level of the SNPs. Results are presented for unstandardized (panel a) and standardized 
(panel b) estimates. Parameters outside of the parentheses indicate those provided in the generating 
population. In parentheses, we provide for WLS (in italics) and ML (in bold) estimation the average 
point estimate and the ratio of the mean SE estimate across the 100 runs over the empirical SE (calculated 
as the standard deviation of the parameter estimates across the 100 runs). The ratio of mean and empirical 
SEs was close to 1 in all cases, although slightly above 1 (i.e., conservative) for standardized estimates of 
residual variance. These SE estimates are expected to be upwardly biased in the standardized case due to 
genetic variance estimates being rescaled to exactly 100%. 
1 
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(.38, 1.15) 
Fg 
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Fg .30 
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1 1 1 1 1 
uX1 uX2 uX3 uX4 uX5 
.60 
(.59, 1.11) 
(.58, 1.10) 
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(.39, 1.10) 
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2S−DWLS−R: Chi−square 2S−DWLS−R: AIC 2S−DWLS−R: CFI 
2S−ML−R: Chi−square 2S−ML−R: AIC 2S−ML−R: CFI 
 
 
a 
WLS: Chi-Square LS: AI  WLS: CFI 
 
   Common Factor 
 
 
 
   Equality Constraints 
 
 
 
   Loading Fixed to 0 
 
 
 
 
0 100 200 300 400 
 
0 100 200 300 400 
 
0.2 0.4 0.6 0.8 1.0 
 
Calculated Chi−square 
b 
 
Calculated AIC 
 
Calculated CFI 
ML: Chi-Square L: I  ML: CFI 
0 100 200 300 400 0 100 200 300 400 0.2 0.4 0.6 0.8 1.0 
  Calculated Chi−square     Calculated AIC     Calculated CFI   
Fig. S2. Model fit indices from Genomic SEM simulations. Model fit indices were compared across the 
100 runs of Genomic SEM using simulated data. Depicted in blue are model fit indices for runs specified 
to match the generating population (i.e., one common factor with freely estimated factor loadings). 
Depicted in green are indices for models specified to have equal factor loadings across all indicators. 
Depicted in red are indices for a model in which the third indicator loading was fixed to 0. Indices favored 
the model that matched the generating population for model chi-square, AIC, and CFI in 100% of cases, 
with the exception that 99 models favored the matching model for AIC with WLS estimation. Indices are 
presented for WLS (panel a) and ML (panel b) estimation. 
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a 
Unstandardized 
 
 
 
 
 
 
 
 
 
 
 
.06 (.03) .09 (.03) .08 (.01) .06 (.03) .10 (.05) 
 
b 
Standardized 
 
 
 
 
 
 
 
 
 
 
 
.26 (.11) .35 (.11) .79 (.07) .91 (.44) .71 (.36) 
 
Fig. S3. Confirmatory factor analysis of genetic p-factor with Genomic SEM. Confirmatory factor 
analyses (CFA) were used to construct a genetically defined p-factor for unstandardized (panel a) and 
standardized estimates (panel b) using WLS estimation. SEs are shown in parentheses. The genetic 
covariance matrix (unstandardized) or genetic correlation matrix (standardized) and associated sampling 
covariance matrix were used as input for Genomic SEM. Indicators are presented as circle to reflect the 
fact that these are unobserved heritability estimates from LDSC. SCZ = schizophrenia; BIP = bipolar 
disorder; DEP = major depressive disorder; PTSD = post-traumatic stress disorder; ANX = anxiety. 
1 
pG 
  .86 (.06)    .53 (.08)  
  .81 (.06)    .29 (.09)  
.46 (.04) 
SCZg BIPg DEPg PTSDg ANXg 
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1 
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.15 (.01) 
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1 1 1 1 1 
uSCZ uBIP uDEP uPT uANX 
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.33 (.02) 
 
.46 (.03) .39 (.02) 
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.50 (.04) 
 
.37 (.03) 
Fig. S4. Confirmatory factor analysis of a genetic factor of neuroticism with Genomic SEM. 
Confirmatory factor analyses (CFA) were used to construct a genetically defined neuroticism factor for 
unstandardized (panel a) and standardized estimates (panel b) using WLS estimation. SEs are shown in 
parentheses. The genetic covariance matrix (unstandardized) or genetic correlation matrix (standardized) 
and associated sampling covariance matrix were used as input for Genomic SEM. Irr = irritability; Feel = 
sensitivity/hurt feelings; fed-up = fed-up feelings; emb = worry too long after embarrassment. 
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Fig. S5. Confirmatory factor analysis of two and three-factor models of neuroticism. Confirmatory 
factor analyses (CFA) based on initial EFAs were used to construct a two-factor (panel a) and three-factor 
(panel b) solution using WLS estimation. The displayed ordering of the variables is maintained across the 
factor solutions for comparative purposes. Standardized values are reported along with SEs in 
parentheses. The genetic correlation matrix (standardized) and associated sampling covariance matrix 
were used as input for Genomic SEM. Irr = irritability; Feel = sensitivity/hurt feelings; fed-up = fed-up 
feelings; emb = worry too long after embarrassment. 
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Fig. S6. Identifying SNPs with increasingly specific effects on neuroticism items. Panel a depicts the 
flow chart for the iterative process that can be undertaken to identify SNPs with increasingly specific 
effects on sets of traits. Any mention of significance is at the genome-wide level (p < 5e-8). Values inside 
and outside of the dotted red circle are negative and positive, respectively. Panels b-d depict polar plots 
for the item-level Z-statistics for exemplar SNPs identified as genome-wide significant for the one-factor 
solution (panel b), the first factor for the two-factor solution (panel c), and the third factor for the three- 
factor solution (panel d). The same coloring within item names denotes loading on the same factor. In 
panel b, a SNP identified as significant for a common factor shows highly consistent effects across items. 
In panels c and d, SNPs identified as significant for factors defined by only a subset of items show 
consistent effects with respect to magnitude and direction only within these factors. 
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a 
b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S7. Heatmap of genetic associations among anthropometric traits. Genetic covariance (panel a) 
and correlation (panel b) matrices with parameters estimated from multivariate LDSC. Visual inspection 
indicates two clusters in the upper left and lower right corner of the heatmap. BMI = body mass index; 
WHR = waist-hip ratio; CO = childhood obesity; IHC = infant head circumference; BL = birth length; 
BW = birth weight. 
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Fig S8. Confirmatory factor analysis of multivariate genetic architecture of anthropometric traits 
using Genomic SEM. Confirmatory factor analyses (CFA) informed by an initial exploratory factor 
analysis were used to construct latent overweight and early life growth factors for unstandardized (panel 
a) and standardized estimates (panel b) using WLS estimation. SEs are shown in parentheses. The genetic 
covariance matrix (unstandardized) or genetic correlation matrix (standardized) and associated sampling 
covariance matrix were used as input for Genomic SEM. BMI = body mass index; WHR = waist-hip 
ratio; CO = childhood obesity; IHC = infant head circumference; BL = birth length; BW = birth weight. 
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Fig. S9. Reproducing GWIS findings using Genomic SEM. Results from Genomic SEM in which the 
genetic component of educational achievement was simultaneously regressed on the genetic components 
of bipolar disorder and schizophrenia. The genetic covariance (unstandardized; panel a) and genetic 
correlation (standardized; panel b) matrices, and associated sampling covariance matrices, estimated from 
multivariate LDSC were used as input for Genomic SEM. 
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Fig. S10. Quantile-quantile plot of multivariate GWAS p-values for the p-factor and neuroticism. 
Expected −log10(p)-values are those expected under the null hypothesis. The shaded area indicates the 
95% confidence interval under the null. The multivariate GWAS was conducted using Genomic SEM 
with WLS estimation. 
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Fig. S11a. Manhattan plot for univariate Schizophrenia GWAS (Genomic SEM results 
superimposed). The gray dashed line marks the threshold for genome wide significance (p < 5 × 10-8). 
Black triangles denote independent hits for the p-factor that were not in LD with independent hits for the 
univariate GWAS. Purple diamonds denote independent hits for the univariate indicators that were not in 
LD with independent hits for the p-factor. Grey stars denote independent hits for QSNP. 
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Fig. S11b. Manhattan plot for univariate Bipolar GWAS (Genomic SEM results superimposed). 
The gray dashed line marks the threshold for genome wide significance (p < 5 × 10-8). Black triangles 
denote independent hits for the p-factor that were not in LD with independent hits for the univariate 
GWAS. Purple diamonds denote independent hits for the univariate indicators that were not in LD with 
independent hits for the p-factor. Grey stars denote independent hits for QSNP. 
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Fig. 11c. Manhattan plot for univariate Major Depression GWAS (Genomic SEM results 
superimposed). The gray dashed line marks the threshold for genome wide significance (p < 5 × 10-8). 
Black triangles denote independent hits for the p-factor that were not in LD with independent hits for the 
univariate GWAS. Purple diamonds denote independent hits for the univariate indicators that were not in 
LD with independent hits for the p-factor. Grey stars denote independent hits for QSNP. 
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Fig. S11d. Manhattan plot for Post-Traumatic Stress Disorder GWAS (Genomic SEM results 
superimposed). The gray dashed line marks the threshold for genome wide significance (p < 5 × 10-8). 
Black triangles denote independent hits for the p-factor that were not in LD with independent hits for the 
univariate GWAS. Purple diamonds denote independent hits for the univariate indicators that were not in 
LD with independent hits for the p-factor. Grey stars denote independent hits for QSNP. 
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Fig. S11e. Manhattan plot for univariate Anxiety GWAS (Genomic SEM results superimposed). 
The gray dashed line marks the threshold for genome wide significance (p < 5 × 10-8). Black triangles 
denote independent hits for the p-factor that were not in LD with independent hits for the univariate 
GWAS. Purple diamonds denote independent hits for the univariate indicators that were not in LD with 
independent hits for the p-factor. Grey stars denote independent hits for QSNP. 
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Fig. S12. Manhattan plots of hits from Genomic SEM. Genomic SEM (with WLS estimation) was used to 
conduct multivariate GWASs of the p-factor (panel a) and neuroticism (panel b). The gray dashed line marks the 
threshold for genome wide significance (p < 5 × 10-8). In both panels, black triangles denote independent hits for 
SNP effects from the GWAS of the general factor. 
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Fig. S13. Polar plots of item-level effects for genome-wide significant effects on common factors and 
for QSNP. All plots display the betas for the items standardized with respect to the total variance in the 
phenotype. Values inside and outside of the dotted red circle are negative and positive, respectively. The 
top panel displays item-level betas for a SNP that was genome-wide significant and produced low QSNP 
estimates for the p-factor (panel a; factor p-value = 7.78e-13; QSNP p-value = 0.57) and neuroticism (panel 
b; factor p-value = 5.06e-12; QSNP p-value = 0.77). As expected, the estimates in the top panel are both 
large in magnitude and consistent in direction across the items. The bottom panel displays item-level 
effects that produced genome-wide significant QSNP estimates for the p-factor (panel c; factor p-value = 
5.32e-3; QSNP p-value = 2.02e-8) and neuroticism (panel d; factor p-value = 2.40e-4; QSNP p-value = 
1.66e-14). Unlike the top panel, these SNPs are characterized by discrepant effects across the items with 
respect to magnitude and direction. This indicates that the QSNP test of heterogeneity is appropriately 
capturing discrepancy across genetic effects for the included phenotypes. 
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Fig. S14. Histograms of –log10 p-values for hits on p-factor. Histograms of –log10 p-values for the 
684 non-independent SNPs that were genome wide significant for the p-factor using WLS estimation, but 
were not identified as significant in any of the individual GWASs. The vertical red line indicates genome 
wide significance. 
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Fig. S15. Histograms of –log10 p-values for hits on neuroticism factor. Histograms of –log10 p-values 
for the 2,540 non-independent SNPs that were genome wide significant for neuroticism using WLS 
estimation, but were not identified as significant in any of the individual GWASs. The vertical red line 
indicates genome wide significance. 
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Fig. S16. Quantile-quantile plot for QSNP. Estimates are from WLS estimation for the p-factor (panel a) 
and neuroticism (panel b). Expected −log10 p-values are those expected under the null hypothesis. The 
shaded area indicates the 95% confidence interval under the null. As some QSNP estimates for neuroticism 
were quite large, p-values < 5-20 were set to 5-20. 
a b 
Genomic SEM 29 
 
Heterogeneity in Indicators 
 
rs111492783 
rs4298967 
rs227199 
rs9490512 
rs933738 
rs1974652 
rs13125131 
rs11030107 
rs12647922 
rs67988891 
rs13256013 
rs6465608 
rs1805007 
rs10027492 
rs4885657 
rs1906252 
rs747880 
rs35091253 
rs1641155 
rs115319635 
rs2837381 
rs56238684 
rs55666439 
rs12364432 
rs11719137 
rs663640 
rs34495106 
rs718139 
rs10007721 
rs61747555 
rs12477961 
rs1845464 
rs3764002 
rs429358 
rs10460551 
rs13021256 
rs4886057 
rs7852243 
rs7526108 
rs4129585 
rs4851649 
rs34811474 
rs62036613 
rs11599236 
rs2396765 
rs35999162 
rs1217106 
rs34862781 
rs353547 
rs893949 
rs4953150 
rs651548 
rs6067019 
rs12994592 
rs2647234 
rs362307 
rs12895055 
rs28606370 
rs3095335 
rs10490220 
rs2242660 
rs613872 
rs2160515 
rs17503738 
rs7727738 
rs9876664 
rs8054556 
rs11204421 
rs507506 
 
Mood 
Miser 
F 
ed 
v ense Emb 
Ner 
Guilt 
y 
Irr eel up ous 
y 
es 
Lonely − orr   v 
W T 
F Ner 
N
e
rv
o
u
s
 
Heterogeneity in Indicators 
 
 
rs111492783 
rs4298967 
rs227199 
rs9490512 
rs933738 
rs1974652 
rs13125131 
rs11030107 
rs12647922 
rs67988891 
rs13256013 
rs6465608 
rs1805007 
rs10027492 
rs4885657 
rs1906252 
rs747880 
rs35091253 
rs1641155 
rs115319635 
rs2837381 
rs56238684 
rs55666439 
rs12364432 
rs11719137 
rs663640 
rs34495106 
rs 18139 
rs10007721 
rs61747555 
rs12477961 
rs1845464 
rs3764002 
rs429358 
rs10460551 
rs13021256 
rs4886057 
rs7852243 
rs7526108 
rs4129585 
rs4851649 
rs34811474 
rs 2036613 
rs 1599236 
rs2396765 
rs35999162 
rs1217106 
rs34862781 
rs353547 
rs893949 
rs4953150 
rs651548 
rs6067019 
rs12994592 
rs2647234 
rs362307 
rs1 895055 
rs28606370 
rs3095335 
rs 0490220 
rs2242660 
rs613872 
rs2160515 
rs17503738 
rs7727738 
rs9876664 
rs8054556 
rs11204421 
rs507506 
 
 
Fig. S17. Heatmap of univariate betas for neuroticism indicators for QSNP hits. The heatmap depicts 
univariate item-specific betas for the 69 lead SNPs for QSNP identified using WLS estimation for 
neuroticism. Items are on the x-axis. SNPs are on the y-axis. Cells depicted in red, white, and blue 
indicate negative, near zero, and positive betas, respectively. As expected, individual rows indicate 
substantial heterogeneity across the indicators for hits on QSNP. 
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a b 
the common factor and QSNP effects. The association 
between the p-values for SNP effects on the common factor (x-axis) and the p-values for QSNP (y-axis) are 
plotted for WLS estimation of the p-factor (panel a) and neuroticism (panel b). The red line reflects the 
regression line for the common factor p-value predicting itself (i.e., a slope of 1), with dots above the line 
estimated as less significant for QSNP. The correlation between these two outcomes was .02 for the p-factor 
and .05 for neuroticism. 
 
 
 
 
 
 
 
 
 
 
Fig. S18. Association between SNP effects on 
Genomic SEM 31 
 
Significant for only Neuroticism 
Significant for only Univariate GWAS 
 
 
 
b 
 
 
 
 
 
 
 
 
 
0 5 10 15 20 25 30 35 
 
Q(SNP) −log10(p) 
Q(SNP) −log10(p) 
 
 
 
 
 
 
 
 
 
 
0 5 10 15 20 25 30 35 
 
 
Q(SNP) −log10(p) 
 
Q(SNP) −log10(p) 
Fig. S19. QSNP –log10 p-values for common-factor and indicator-specific hits. Results are depicted for 
WLS estimation of the p-factor (panel a) and neuroticism (panel b). There were 684 non-independent 
SNPs identified as genome-wide significant for p-factor, but not the univariate GWAS, and 1,022 
indicator-specific SNPs. For neuroticism, there were 2,540 non-independent hits specific to the common 
factor and 6,523 hits specific to the indicators. The average –log10 QSNP p-value was 0.61 for hits only on 
the p-factor and 1.81 for hits specific to the univariate indicators. For neuroticism, the average –log10 
QSNP p-value was 0.95 for hits unique to the common factor and 5.95 for hits unique to the indicators. 
Thus, QSNP values were generally more significant for those SNPs not identified as significant for the 
common factor. 
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Fig. S20. MTAG predicting Genomic SEM specified as MTAG. Panel a depicts the MTAG beta 
predicting the Genomic SEM formulation of MTAG beta (b = .998, intercept = -1.56E-7, R2 = .994). 
Panel b depicts MTAG Z-statistic predicting the Genomic SEM formulation of MTAG Z-statistic (b = 
.999, intercept = 2.65E-4, R2 = .999). For both panels, the red line reflects the regression line for MTAG 
predicting itself (i.e., a slope of 1). 
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Fig. S21. Comparison of parcel p-values for low versus high QSNP estimates. Histograms shown for 
SNPs that produced genome wide significant hits for at least one of the parcels split across high (QSNP p- 
value < 5e-8; 1,090 SNPs; panel a) and low (p > 5e-3; 3,685 SNPs; panel b) QSNP estimates as estimated 
using WLS for the common neuroticism factor. For those SNPs characterized by a larger degree of 
heterogeneity, as indexed by QSNP, there was a corresponding heterogeneity in the p-values at the level of 
the parcel. 
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Fig. S22. UK Biobank p-factor. Standardized output of phenotypic p-factor constructed from UKB 
phenotypes for out of sample prediction using p-factor polygenic scores. PSY = psychotic experiences; 
DEP = depressive symptoms; PTSD = symptoms of post-traumatic stress disorder; ANX = anxious 
symptoms. 
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Fig. S23. ML Estimates from GWIS and anthropometric trait Genomic SEM models. Results are 
presented for standardized output for the multiple regression model of GWIS (panel a) and the 
confirmatory factor model of anthropometric traits (panel b). SEs are shown in parentheses. The genetic 
correlation matrix (standardized) and associated sampling covariance matrix were used as input for 
Genomic SEM. BMI = body mass index; WHR = waist-hip ratio; CO = childhood obesity; IHC = infant 
head circumference; BL = birth length; BW = birth weight. 
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Fig. S24. ML estimates for neuroticism and p-factor Genomic SEM models. Results are presented for 
standardized output for the confirmatory factor models of the p-factor (panel a) and neuroticism (panel b). 
The genetic correlation matrix (standardized) and associated sampling covariance matrix were used as 
input for Genomic SEM. SEs are shown in parentheses. SCZ = schizophrenia; BIP = bipolar disorder; 
DEP = major depressive disorder; PTSD = post-traumatic stress disorder; ANX = anxiety. Irr = 
irritability; Feel = sensitivity/hurt feelings; fed-up = fed-up feelings; emb = worry too long after 
embarrassment. 
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Fig. S25. Quantile-quantile plot of multivariate GWAS p-values for p-factor and neuroticism (ML 
estimation). Estimates are from ML estimation for the p-factor (panel a), neuroticism (panel b), QSNP 
estimates for the p-factor (panel c), and QSNP estimates for neuroticism (panel d). Expected −log10 p- 
values are those expected under the null hypothesis. The shaded area indicates the 95% confidence 
interval under the null. As some QSNP estimates for neuroticism were quite large, p-values < 5
-20 were set 
to 5-20. 
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Fig. S26. Associations between ML and WLS p values. Scatter plot comparing p-values between WLS 
(y-axis) and ML (x-axis) estimation for the p-factor (panel a), neuroticism (panel b), QSNP for the p-factor 
(panel c), and QSNP for neuroticism (panel d). The red line reflects the regression line for ML predicting 
itself (i.e., a slope of 1), with dots above the line estimated as less significant for WLS. The correlation 
between the two sets of common factor p-values (top panel) was .15 for the p-factor and .94 for 
neuroticism. The correlation between the two QSNP statistics (bottom panel) for neuroticism was > .99 and 
.77 for the p-factor . Thus, the rank-ordering is largely maintained across the estimation methods, but may 
diverge, in particular, for factor effects. 
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Fig. S27. Biological annotation of QSNP of p-factor, neuroticism, and QSNP of neuroticism. Results from 
tissue enrichment analyses conducted using DEPICT based on Genomic SEM results for QSNP of the p- 
factor (panel a), neuroticism (panel b) and QSNP estimation for neuroticism (panel c) using ML estimation. 
The red, dashed line indicates the false discovery rate at .05. As expected, the majority of enriched tissues 
were in the nervous system for both common factor and QSNP estimates. 
−
lo
g
1
0
 (
P
 v
a
lu
e
) 
−
lo
g
1
0
 (
P
 v
a
lu
e
) 
−
lo
g
1
0
 (
P
 v
a
lu
e
) 
Genomic SEM 40 
 
L
P
M
 t
o
 L
o
g
is
ti
c
 B
e
ta
 
0
.0
2
 0
.0
4
 0
.0
6
 0
.0
8
 0
.1
0
 
 
a b c 
 
 
 
 
 
 
 
 
 
 
 
 
−0.02 0.00 0.02 0.04 0.06 0.08 
Logistic Beta 
−0.02 0.00 0.02 0.04 0.06 0.08 
Logistic Beta 
0 2 4 6 
Logistic Z−Statistic 
Fig S28. Associations between regression coefficients from logistic regression model and linear 
probability model. 200 datasets were simulated with 100,000 observations each in which a continuously 
distributed liability was specified to be a linear function of a biallelic autosomal SNP and a normally 
distributed residual. Population effect sizes were randomly generated for each simulation, from within the 
range of 0 to .04 SD units per effect allele. The outcome was then dichotomized using a randomly 
generated threshold for each simulation within the range of -1.96 and 1.96 standard deviations from the 
mean of the liability distribution (i.e. the population prevalence of cases ranged between 2.5% to 97.5%). 
The population minor allele frequency of the SNP was randomly generated for each replication from 
within the range of 0 to .5. Panel a depicts the association between the betas obtained from a logistic 
regression of a SNP predicting the dichotomous outcome (x-axis) and from the betas obtained from a 
linear probability model (LPM) applied to the same data (y-axis; r = .70). Panel b depicts the same x-axis 
and the LPM output converted to logistic betas on the y-axis (r > .99). Panel c depicts the z-statistics (the 
coefficient divided by its standard error) for the logistic betas (x-axis) and LPM betas (y-axis, r > .99). 
The red lines depict the regression line (slope = 1, intercept = 0) for the logistic betas (panel b) and 
logistic z-statistics (panel c) predicting themselves. Thus, LPM output must be rescaled before effect sizes 
(i.e., regression coefficients) can be used for multivariate GWAS in Genomic SEM. However, LPM Z 
statistics can be used directly for LDSC to produce heritabilities and genetic covariances (the liability 
scale estimates should still be requested). 
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Fig S29. Associations between betas standardized using reference panel or sample MAF. 30,000 
SNPs were randomly selected from the mood UK Biobank phenotype and converted to approximate 
logistic regression effects and scaled relative to unit-variance scaled liability using either MAFs from a 
reference panel (1000 Genomes Phase 3; x-axis) or MAFs from the sample (UK Biobank; y-axis). 
Regardless of the MAFs used for standardization, the correspondence between the betas was very strong 
(r = .987, slope = 1.044, intercept = -6.54e-6). Although the use of either sample or reference MAF may 
be appropriate for different reasons, these results indicate that the decision will produce very similar 
estimates. 
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Fig. S30. Associations between model 2 values computed from summary data and model 2 values 
computed from raw data. Raw data-based estimates of model 2 were computed directly from the data 
using lavaan. Summary data-based estimates of model 2 were computed using the S and V matrices with 
WLS (left) and ML (right) estimation. The red line in the middle and left panel reflects the regression line 
for the raw data-based model 2 predicting itself. The blue line in the right panel reflects the regression 
line for the WLS 2 predicting itself. 
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Fig. S31. Distributions of calculated and theoretical 2 statistics. Comparison between distribution of 
2 values for model estimated from S and V matrices using WLS (left column) and ML (middle column) 
against a theoretical 2 distribution. The right column compares the distributions of WLS (blue bars) and 
ML (green bars). 
  WLS 2 df  ML 2 df   Comparison 2 df  
  WLS 9 df    ML 9 df    Comparison 9 df  
Genomic SEM 44 
 
2S−DWLS−R: 2 df Comparison: 2 df 2S−ML−R: 2 df 
2S−DWLS−R: 5 df Comparison: 5 df 2S−ML−R: 5 df 
2S−DWLS−R: 9 df Comparison: 9 df 2S−ML−R: 9 df 
R 
− 
M
L 
− 
2
S 
R 
− 
M
L 
− 
2
S 
R 
− 
M
L 
− 
2
S 
2S−DWLS−R 
2S−DWLS−R 
2S−DWLS−R WLS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.9990 0.9992 0.9994 0.9996 0.9998 1.0000 
 
 
 
0.9994 0.9995 0.9996 0.9997 0.9998 0.9999 1.0000 
 
 
 
0.99965 0.99975 0.99985 0.99995 
 
CFI from lavaan 
 
CFI from lavaan 
 
estimated CFI 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.9992 0.9994 0.9996 0.9998 1.0000 
 
0.9996 0.9997 0.9998 0.9999 1.0000 
 
0.9992 0.9994 0.9996 0.9998 1.0000 
 
CFI from lavaan 
 
CFI from lavaan 
 
estimated CFI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.9988 0.9990 0.9992 0.9994 0.9996 0.9998 1.0000 
 
0.9996 0.9997 0.9998 0.9999 1.0000 
 
0.9996 0.9997 0.9998 0.9999 1.0000 
 
CFI from lavaan 
 
CFI from lavaan 
 
estimated CFI 
Fig. S32. Associations between CFI values derived from summary data and CFI values derived 
from raw data. Summary data-based estimates of CFI are depicted for models estimated using WLS (left 
column) and ML (middle column). We also present comparisons of the CFI from models estimated with 
ML and those estimated with WLS(right column). All CFI estimates were bounded at 1. 
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Fig. S33. Genomic SEM models for estimating QSNP. Red lines and parameters are fixed from Step 1, 
and black lines and parameters are freely estimated in Step 2. 
! 
Genomic SEM 46 
 
 
 
 
 
Fig. S34. Null distributions of QSNP for 1,000 simulations per model. Red lines for all panels depict the 
chi-square distribution with the relevant df. The top, middle, and bottom panels depict the sampling 
distributions for 3, 4, and 5 df, respectively. The left-most column shows estimates for WLS, the middle 
column estimates for ML and the right-most column overlays the WLS (depicted in light blue) and ML 
(light green) QSNP estimates. 
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Fig. S35. Associations between QSNP and theoretical 
2 distributions. Associations shown for models 
estimated using WLS (left column) and ML estimates (middle column). Red lines depict the 2 
distribution plotted against itself, with values below the line indicating under-estimated effects. The right 
column depicts WLS and ML plotted against one another. The blue line depicts WLS plotted against 
itself, with values above the line indicating QSNP estimates that were estimated as larger for ML. 
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